<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>PhD thesis</title>
  <meta name="description" content="This is a PhD thesis written in real-time in Rstudio">
  <meta name="generator" content="bookdown 0.7 and GitBook 2.6.7">

  <meta property="og:title" content="PhD thesis" />
  <meta property="og:type" content="book" />
  
  
  <meta property="og:description" content="This is a PhD thesis written in real-time in Rstudio" />
  <meta name="github-repo" content="eliaseythorsson/phd_thesis" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="PhD thesis" />
  
  <meta name="twitter:description" content="This is a PhD thesis written in real-time in Rstudio" />
  

<meta name="author" content="Elías Sæbjörn Eyþórsson">


<meta name="date" content="2018-12-21">

  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  
<link rel="prev" href="conclusions.html">

<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">PhD Thesis Under Construction</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Preamble</a></li>
<li class="chapter" data-level="2" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>2</b> Introduction</a><ul>
<li class="chapter" data-level="2.1" data-path="intro.html"><a href="intro.html#clinical-manifestations-of-streptococcus-pneumoniae"><i class="fa fa-check"></i><b>2.1</b> Clinical manifestations of <em>Streptococcus pneumoniae</em></a><ul>
<li class="chapter" data-level="2.1.1" data-path="intro.html"><a href="intro.html#acuteotitismediaintroduction"><i class="fa fa-check"></i><b>2.1.1</b> Acute otitis media</a></li>
<li class="chapter" data-level="2.1.2" data-path="intro.html"><a href="intro.html#pneumonia"><i class="fa fa-check"></i><b>2.1.2</b> Pneumonia</a></li>
<li class="chapter" data-level="2.1.3" data-path="intro.html"><a href="intro.html#invasive-pneumococcal-disease"><i class="fa fa-check"></i><b>2.1.3</b> Invasive pneumococcal disease</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="intro.html"><a href="intro.html#pneumococcal-vaccines"><i class="fa fa-check"></i><b>2.2</b> Pneumococcal vaccines</a><ul>
<li class="chapter" data-level="2.2.1" data-path="intro.html"><a href="intro.html#a-brief-history-of-pneumococcal-vaccination"><i class="fa fa-check"></i><b>2.2.1</b> A brief history of pneumococcal vaccination</a></li>
<li class="chapter" data-level="2.2.2" data-path="intro.html"><a href="intro.html#the-impact-of-pneumococcal-conjugate-vaccines-on-otitis-media"><i class="fa fa-check"></i><b>2.2.2</b> The impact of pneumococcal conjugate vaccines on otitis media</a></li>
<li class="chapter" data-level="2.2.3" data-path="intro.html"><a href="intro.html#intro-pneumonia-impact"><i class="fa fa-check"></i><b>2.2.3</b> The impact of pneumococcal conjugate vaccines on pneumonia</a></li>
<li class="chapter" data-level="2.2.4" data-path="intro.html"><a href="intro.html#intro-ipd-impact"><i class="fa fa-check"></i><b>2.2.4</b> The impact of pneumococcal conjugate vaccines on invasive pneumococcal disease</a></li>
</ul></li>
<li class="chapter" data-level="2.3" data-path="intro.html"><a href="intro.html#cea-introduction"><i class="fa fa-check"></i><b>2.3</b> Cost-effectiveness in the context of pneumococcal conjugate vaccination</a><ul>
<li class="chapter" data-level="2.3.1" data-path="intro.html"><a href="intro.html#vaccine-efficacy-assumptions-in-economic-analyses-of-pneumococcal-conjugate-vaccines"><i class="fa fa-check"></i><b>2.3.1</b> Vaccine efficacy assumptions in economic analyses of pneumococcal conjugate vaccines</a></li>
<li class="chapter" data-level="2.3.2" data-path="intro.html"><a href="intro.html#assumptions-regarding-costs-and-utilities-in-economic-analyses-of-pneumococcal-vaccines"><i class="fa fa-check"></i><b>2.3.2</b> Assumptions regarding costs and utilities in economic analyses of pneumococcal vaccines</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="aims.html"><a href="aims.html"><i class="fa fa-check"></i><b>3</b> Aims</a></li>
<li class="chapter" data-level="4" data-path="methods.html"><a href="methods.html"><i class="fa fa-check"></i><b>4</b> Materials and methods</a><ul>
<li class="chapter" data-level="4.1" data-path="methods.html"><a href="methods.html#datasources"><i class="fa fa-check"></i><b>4.1</b> Data collection and sources</a><ul>
<li class="chapter" data-level="4.1.1" data-path="methods.html"><a href="methods.html#statisticsiceland"><i class="fa fa-check"></i><b>4.1.1</b> Statistics Iceland</a></li>
<li class="chapter" data-level="4.1.2" data-path="methods.html"><a href="methods.html#patientregistry"><i class="fa fa-check"></i><b>4.1.2</b> Landspitali University Hospital patient registry</a></li>
<li class="chapter" data-level="4.1.3" data-path="methods.html"><a href="methods.html#primarycareregistry"><i class="fa fa-check"></i><b>4.1.3</b> The Primary Care Registry</a></li>
<li class="chapter" data-level="4.1.4" data-path="methods.html"><a href="methods.html#vaccineregistry"><i class="fa fa-check"></i><b>4.1.4</b> The National Vaccine Registry</a></li>
<li class="chapter" data-level="4.1.5" data-path="methods.html"><a href="methods.html#prescriptionregistry"><i class="fa fa-check"></i><b>4.1.5</b> The National Drug Prescription Registry</a></li>
<li class="chapter" data-level="4.1.6" data-path="methods.html"><a href="methods.html#reimbursementdatabase"><i class="fa fa-check"></i><b>4.1.6</b> Reimbursement database of Icelandic Health Insurance</a></li>
</ul></li>
<li class="chapter" data-level="4.2" data-path="methods.html"><a href="methods.html#paper1"><i class="fa fa-check"></i><b>4.2</b> Impact on otitis media with treatment failure (Paper I)</a></li>
<li class="chapter" data-level="4.3" data-path="methods.html"><a href="methods.html#paper2"><i class="fa fa-check"></i><b>4.3</b> Impact on primary care visits for acute otitis media (Paper II)</a></li>
<li class="chapter" data-level="4.4" data-path="methods.html"><a href="methods.html#paper3"><i class="fa fa-check"></i><b>4.4</b> Impact on outpatient antimicrobial prescriptions (Paper III)</a></li>
<li class="chapter" data-level="4.5" data-path="methods.html"><a href="methods.html#paper4"><i class="fa fa-check"></i><b>4.5</b> Impact on tympanostomy tube procedures (Paper IV)</a></li>
<li class="chapter" data-level="4.6" data-path="methods.html"><a href="methods.html#paper5"><i class="fa fa-check"></i><b>4.6</b> Impact on respiratory associated hospitalizations (Paper V)</a></li>
<li class="chapter" data-level="4.7" data-path="methods.html"><a href="methods.html#paper6"><i class="fa fa-check"></i><b>4.7</b> Impact and cost-effectiveness analysis (Paper VI)</a><ul>
<li class="chapter" data-level="4.7.1" data-path="methods.html"><a href="methods.html#data-sources"><i class="fa fa-check"></i><b>4.7.1</b> Data sources</a></li>
<li class="chapter" data-level="4.7.2" data-path="methods.html"><a href="methods.html#statistical-analysis"><i class="fa fa-check"></i><b>4.7.2</b> Statistical analysis</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="results.html"><a href="results.html"><i class="fa fa-check"></i><b>5</b> Results</a><ul>
<li class="chapter" data-level="5.1" data-path="results.html"><a href="results.html#datasourcesresults"><i class="fa fa-check"></i><b>5.1</b> Data collection and sources</a><ul>
<li class="chapter" data-level="5.1.1" data-path="results.html"><a href="results.html#statistics-iceland"><i class="fa fa-check"></i><b>5.1.1</b> Statistics Iceland</a></li>
<li class="chapter" data-level="5.1.2" data-path="results.html"><a href="results.html#landspitali-university-hospital-patient-registry"><i class="fa fa-check"></i><b>5.1.2</b> Landspitali University Hospital patient registry</a></li>
<li class="chapter" data-level="5.1.3" data-path="results.html"><a href="results.html#the-primary-care-registry"><i class="fa fa-check"></i><b>5.1.3</b> The Primary Care Registry</a></li>
<li class="chapter" data-level="5.1.4" data-path="results.html"><a href="results.html#the-national-vaccine-registry"><i class="fa fa-check"></i><b>5.1.4</b> The National Vaccine Registry</a></li>
<li class="chapter" data-level="5.1.5" data-path="results.html"><a href="results.html#the-national-drug-prescription-registry"><i class="fa fa-check"></i><b>5.1.5</b> The National Drug Prescription Registry</a></li>
<li class="chapter" data-level="5.1.6" data-path="results.html"><a href="results.html#reimbursement-database-of-icelandic-health-insurance"><i class="fa fa-check"></i><b>5.1.6</b> Reimbursement database of Icelandic Health Insurance</a></li>
</ul></li>
<li class="chapter" data-level="5.2" data-path="results.html"><a href="results.html#paper1results"><i class="fa fa-check"></i><b>5.2</b> Impact on otitis media with treatment failure (Paper I)</a></li>
<li class="chapter" data-level="5.3" data-path="results.html"><a href="results.html#paper2results"><i class="fa fa-check"></i><b>5.3</b> Impact on primary care visits for acute otitis media (Paper II)</a></li>
<li class="chapter" data-level="5.4" data-path="results.html"><a href="results.html#paper3results"><i class="fa fa-check"></i><b>5.4</b> Impact on outpatient antimicrobial prescriptions (Paper III)</a></li>
<li class="chapter" data-level="5.5" data-path="results.html"><a href="results.html#paper4results"><i class="fa fa-check"></i><b>5.5</b> Impact on tympanostomy tube procedures (Paper IV)</a></li>
<li class="chapter" data-level="5.6" data-path="results.html"><a href="results.html#paper5results"><i class="fa fa-check"></i><b>5.6</b> Impact on respiratory associated hospitalizations (Paper V)</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="discussion.html"><a href="discussion.html"><i class="fa fa-check"></i><b>6</b> Discussion</a><ul>
<li class="chapter" data-level="6.1" data-path="discussion.html"><a href="discussion.html#main-findings"><i class="fa fa-check"></i><b>6.1</b> Main findings</a></li>
<li class="chapter" data-level="6.2" data-path="discussion.html"><a href="discussion.html#datasourcesdiscussion"><i class="fa fa-check"></i><b>6.2</b> Data collection and sources</a></li>
<li class="chapter" data-level="6.3" data-path="discussion.html"><a href="discussion.html#epidemiology-and-impact-of-phid-cv10-on-otitis-media-in-iceland-papers-i-ii-iii-v-and-vi"><i class="fa fa-check"></i><b>6.3</b> Epidemiology and impact of PHiD-CV10 on otitis media in Iceland (Papers I, II, III, V and VI)</a><ul>
<li class="chapter" data-level="6.3.1" data-path="discussion.html"><a href="discussion.html#epidemiology-of-acute-otitis-media-in-iceland-papers-ii-and-v"><i class="fa fa-check"></i><b>6.3.1</b> Epidemiology of acute otitis media in Iceland (Papers II and V)</a></li>
<li class="chapter" data-level="6.3.2" data-path="discussion.html"><a href="discussion.html#impact-on-primary-care-visits-for-otitis-media-papers-ii-and-vi"><i class="fa fa-check"></i><b>6.3.2</b> Impact on primary care visits for otitis media (Papers II and VI)</a></li>
<li class="chapter" data-level="6.3.3" data-path="discussion.html"><a href="discussion.html#impact-on-pediatric-emergency-department-visits-for-acute-otitis-media-paper-i"><i class="fa fa-check"></i><b>6.3.3</b> Impact on pediatric emergency department visits for acute otitis media (Paper I)</a></li>
<li class="chapter" data-level="6.3.4" data-path="discussion.html"><a href="discussion.html#impact-on-outpatient-antimicrobial-prescriptions-for-otitis-media-paper-iii"><i class="fa fa-check"></i><b>6.3.4</b> Impact on outpatient antimicrobial prescriptions for otitis media (Paper III)</a></li>
<li class="chapter" data-level="6.3.5" data-path="discussion.html"><a href="discussion.html#evidence-of-herd-effect-of-phid-cv10-on-the-incidence-of-otitis-media-in-the-unvaccinated-population-papers-ii-and-vi"><i class="fa fa-check"></i><b>6.3.5</b> Evidence of herd-effect of PHiD-CV10 on the incidence of otitis media in the unvaccinated population (Papers II and VI)</a></li>
<li class="chapter" data-level="6.3.6" data-path="discussion.html"><a href="discussion.html#impact-on-acute-otitis-media-with-treatment-failure-paper-i"><i class="fa fa-check"></i><b>6.3.6</b> Impact on acute otitis media with treatment failure (Paper I)</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="discussion.html"><a href="discussion.html#impact-of-phid-cv10-on-tympanostomy-tube-placements-paper-iv"><i class="fa fa-check"></i><b>6.4</b> Impact of PHiD-CV10 on tympanostomy tube placements (Paper IV)</a><ul>
<li class="chapter" data-level="6.4.1" data-path="discussion.html"><a href="discussion.html#impact-on-hospital-admissions-for-otitis-media-paper-v"><i class="fa fa-check"></i><b>6.4.1</b> Impact on hospital admissions for otitis media (Paper V)</a></li>
</ul></li>
<li class="chapter" data-level="6.5" data-path="discussion.html"><a href="discussion.html#impact-of-phid-cv10-on-pneumonia-hospitalizations-in-iceland-papers-v-and-vi"><i class="fa fa-check"></i><b>6.5</b> Impact of PHiD-CV10 on pneumonia hospitalizations in Iceland (Papers V and VI)</a><ul>
<li class="chapter" data-level="6.5.1" data-path="discussion.html"><a href="discussion.html#evidence-of-herd-effect-of-phid-cv10-on-pneumonia-hospitalization-in-the-unvaccinated-population-papers-v-and-vi"><i class="fa fa-check"></i><b>6.5.1</b> Evidence of herd-effect of PHiD-CV10 on pneumonia hospitalization in the unvaccinated population (Papers V and VI)</a></li>
</ul></li>
<li class="chapter" data-level="6.6" data-path="discussion.html"><a href="discussion.html#impact-of-phid-cv10-on-invasive-pneumococcal-disease-papers-v-and-vi"><i class="fa fa-check"></i><b>6.6</b> Impact of PHiD-CV10 on invasive pneumococcal disease (Papers V and VI)</a></li>
<li class="chapter" data-level="6.7" data-path="discussion.html"><a href="discussion.html#cost-effectiveness-of-introduction-of-phid-cv10-into-the-icelandic-pediatric-vaccination-program-paper-vi"><i class="fa fa-check"></i><b>6.7</b> Cost-effectiveness of introduction of PHiD-CV10 into the Icelandic pediatric vaccination program (Paper VI)</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="conclusions.html"><a href="conclusions.html"><i class="fa fa-check"></i><b>7</b> Conclusions</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">PhD thesis</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="references" class="section level1 unnumbered">
<h1>References</h1>

<div id="refs" class="references">
<div>
<p>Adam, D, and K Fehnle. 2008. “Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.” <em>Vaccine</em> 26 (47): 5944–51. doi:<a href="https://doi.org/10.1016/j.vaccine.2008.08.058">10.1016/j.vaccine.2008.08.058</a>.</p>
</div>
<div>
<p>Ahmed, Sameer, Nina L Shapiro, and Neil Bhattacharyya. 2014. “Incremental health care utilization and costs for acute otitis media in children.” <em>The Laryngoscope</em> 124 (1): 301–5. doi:<a href="https://doi.org/10.1002/lary.24190">10.1002/lary.24190</a>.</p>
</div>
<div>
<p>Alicino, Cristiano, Chiara Paganino, Andrea Orsi, Matteo Astengo, Cecilia Trucchi, Giancarlo Icardi, and Filippo Ansaldi. 2017. “The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.” <em>Vaccine</em> 35 (43). The Authors: 5776–85. doi:<a href="https://doi.org/10.1016/j.vaccine.2017.09.005">10.1016/j.vaccine.2017.09.005</a>.</p>
</div>
<div>
<p>Andersen, P. K., and R. D. Gill. 1982. “Cox’s Regression Model for Counting Processes: A Large Sample Study.” <em>The Annals of Statistics</em> 10 (4): 1100–1120. doi:<a href="https://doi.org/10.1214/aos/1176345976">10.1214/aos/1176345976</a>.</p>
</div>
<div>
<p>Andrade, Luiz Flavio, Grèce Saba, Jean-Damien Ricard, Jonathan Messika, Jacques Gaillat, Pierre Bonnin, Christian Chidiac, et al. 2018. “Health related quality of life in patients with community-acquired pneumococcal pneumonia in France.” <em>Health and Quality of Life Outcomes</em> 16 (1). Health; Quality of Life Outcomes: 28. doi:<a href="https://doi.org/10.1186/s12955-018-0854-6">10.1186/s12955-018-0854-6</a>.</p>
</div>
<div>
<p>Arason, V A, K G Kristinsson, J A Sigurdsson, G Stefánsdóttir, S Mölstad, and S Gudmundsson. 1996. “Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.” <em>BMJ (Clinical Research Ed.)</em> 313 (7054): 387–91. doi:<a href="https://doi.org/10.1136/bmj.313.7054.387">10.1136/bmj.313.7054.387</a>.</p>
</div>
<div>
<p>Arason, Vilhjalmur A, Johann A Sigurdsson, Karl G Kristinsson, and Sigurdur Gudmundsson. 2002. “Tympanostomy tube placements, sociodemographic factors and parental expectations for management of acute otitis media in Iceland.” <em>The Pediatric Infectious Disease Journal</em> 21 (12): 1110–5. doi:<a href="https://doi.org/10.1097/01.inf.0000040702.00373.95">10.1097/01.inf.0000040702.00373.95</a>.</p>
</div>
<div>
<p>Arason, Vilhjalmur A., Johann A. Sigurdsson, Karl G. Kristinsson, Linn Getz, and Sigurdur Gudmundsson. 2005. “Otitis media, tympanostomy tube placement, and use of antibiotics.” <em>Scandinavian Journal of Primary Health Care</em> 23 (3). Taylor &amp; Francis: 184–91. doi:<a href="https://doi.org/10.1080/02813430510031298">10.1080/02813430510031298</a>.</p>
</div>
<div>
<p>Arguedas, A., K. Kvaerner, J. Liese, A.G.M. Schilder, and S.I. Pelton. 2010. “Otitis media across nine countries: Disease burden and management.” <em>International Journal of Pediatric Otorhinolaryngology</em> 74 (12). Elsevier Ireland Ltd: 1419–24. doi:<a href="https://doi.org/10.1016/j.ijporl.2010.09.022">10.1016/j.ijporl.2010.09.022</a>.</p>
</div>
<div>
<p>Austin, D J, K G Kristinsson, and R M Anderson. 1999. “The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.” <em>Proceedings of the National Academy of Sciences of the United States of America</em> 96 (3): 1152–6. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15366{\&amp;}tool=pmcentrez{\&amp;}rendertype=abstract" class="uri">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15366{\&amp;}tool=pmcentrez{\&amp;}rendertype=abstract</a>.</p>
</div>
<div>
<p>Austrian, R, R M Douglas, G Schiffman, A M Coetzee, H J Koornhof, S Hayden-Smith, and R D Reid. 1976. “Prevention of pneumococcal pneumonia by vaccination.” <em>Transactions of the Association of American Physicians</em> 89: 184–94. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14433" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/14433</a>.</p>
</div>
<div>
<p>AUSTRIAN, ROBERT. 1964. “Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia.” <em>Annals of Internal Medicine</em> 60 (5): 759. doi:<a href="https://doi.org/10.7326/0003-4819-60-5-759">10.7326/0003-4819-60-5-759</a>.</p>
</div>
<div>
<p>Austrian, Robert. 1981. “Pneumococcus: the first one hundred years.” <em>Reviews of Infectious Diseases</em> 3 (2): 183–9. doi:<a href="https://doi.org/10.1093/clinids/3.2.183">10.1093/clinids/3.2.183</a>.</p>
</div>
<div>
<p>———. 1999. “A brief history of pneumococcal vaccines.” <em>Drugs &amp; Aging</em> 15 Suppl 1: 1–10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10690790" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/10690790</a>.</p>
</div>
<div>
<p>Backhaus, Erik, Stefan Berg, Rune Andersson, Gunilla Ockborn, Petter Malmström, Mats Dahl, Salmir Nasic, and Birger Trollfors. 2016. “Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.” <em>BMC Infectious Diseases</em> 16 (1): 367. doi:<a href="https://doi.org/10.1186/s12879-016-1648-2">10.1186/s12879-016-1648-2</a>.</p>
</div>
<div>
<p>Ben-Shimol, Shalom, Noga Givon-Lavi, Eugene Leibovitz, Simon Raiz, David Greenberg, and Ron Dagan. 2014. “Near-Elimination of Otitis Media Caused by 13-Valent Pneumococcal Conjugate Vaccine (PCV) Serotypes in Southern Israel Shortly After Sequential Introduction of 7-Valent/13-Valent PCV.” <em>Clinical Infectious Diseases</em> 59 (12): 1724–32. doi:<a href="https://doi.org/10.1093/cid/ciu683">10.1093/cid/ciu683</a>.</p>
</div>
<div>
<p>———. 2016. “Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.” <em>Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America</em> 63 (5): 611–8. doi:<a href="https://doi.org/10.1093/cid/ciw347">10.1093/cid/ciw347</a>.</p>
</div>
<div>
<p>Bennett, Jonathan E., Walton Sumner, Stephen M. Downs, and David M. Jaffe. 2000. “Parents’ Utilities for Outcomes of Occult Bacteremia.” <em>Archives of Pediatrics &amp; Adolescent Medicine</em> 154 (1). American Medical Association: 43–48. doi:<a href="https://doi.org/10-1001/pubs.Pediatr Adolesc Med.-ISSN-1072-4710-154-1-poa9043">10-1001/pubs.Pediatr Adolesc Med.-ISSN-1072-4710-154-1-poa9043</a>.</p>
</div>
<div>
<p>Berg, Are Stuwitz, Christopher Stephen Inchley, Audun Aase, Hans Olav Fjaerli, Reidun Bull, Ingeborg Aaberge, Truls Michael Leegaard, and Britt Nakstad. 2016. “Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage: A Prospective Study.” <em>The Pediatric Infectious Disease Journal</em> 35 (3): e69–75. doi:<a href="https://doi.org/10.1097/INF.0000000000001009">10.1097/INF.0000000000001009</a>.</p>
</div>
<div>
<p>Bergenfelz, Caroline, and Anders P Hakansson. 2017. “Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.” <em>Current Otorhinolaryngology Reports</em> 5 (2): 115–24. doi:<a href="https://doi.org/10.1007/s40136-017-0152-6">10.1007/s40136-017-0152-6</a>.</p>
</div>
<div>
<p>BEUTELS, P., Z. SHKEDY, M. AERTS, and P. VAN DAMME. 2006. “Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface.” <em>Epidemiology and Infection</em> 134 (06): 1158. doi:<a href="https://doi.org/10.1017/S0950268806006418">10.1017/S0950268806006418</a>.</p>
</div>
<div>
<p>Beutels, Philippe, Nancy Thiry, and Pierre Van Damme. 2007. “Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination–a review (2002-2006).” <em>Vaccine</em> 25 (8): 1355–67. doi:<a href="https://doi.org/10.1016/j.vaccine.2006.10.034">10.1016/j.vaccine.2006.10.034</a>.</p>
</div>
<div>
<p>Birnbaum, Howard G, Melissa Morley, Paul E Greenberg, M Cifaldi, and G L Colice. 2002. “Economic burden of pneumonia in an employed population.” <em>Archives of Internal Medicine</em> 161 (2): 2725–31. doi:<a href="https://doi.org/10.1001/archinte.161.22.2725">10.1001/archinte.161.22.2725</a>.</p>
</div>
<div>
<p>Bjarnason, Agnar, Hilmir Asgeirsson, Olafur Baldursson, Karl G Kristinsson, and Magnus Gottfredsson. 2015. “Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.” <em>Infectious Diseases (London, England)</em> 47 (3): 130–36. doi:<a href="https://doi.org/10.3109/00365548.2014.980842">10.3109/00365548.2014.980842</a>.</p>
</div>
<div>
<p>Bjarnason, Skúli, Ingþór Friðriksson, and Jón Benediktsson. 1991. “Tíðni bráðrar miðeyrabólgu hjá börnum á svæði heilsugæslustöðvarinnar Borgarnesi.” <em>Læknablaðið</em> 77 (4): 137–40. <a href="http://www.hirsla.lsh.is/lsh/bitstream/2336/90415/1/L1991-04-77-F3.pdf" class="uri">http://www.hirsla.lsh.is/lsh/bitstream/2336/90415/1/L1991-04-77-F3.pdf</a>.</p>
</div>
<div>
<p>Black, Nick. 1984. “SURGERY FOR GLUE EAR —A MODERN EPIDEMIC.” <em>The Lancet</em> 323 (8381): 835–37. doi:<a href="https://doi.org/10.1016/S0140-6736(84)92280-3">10.1016/S0140-6736(84)92280-3</a>.</p>
</div>
<div>
<p>Black, S, H Shinefield, Bruce Fireman, E Lewis, P Ray, J R Hansen, L Elvin, et al. 2000. “Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.” <em>The Pediatric Infectious Disease Journal</em> 19 (3): 187–95. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10749457" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/10749457</a>.</p>
</div>
<div>
<p>Black, Steven B, and H Shinefield. 2002. “Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.” <em>Eur J Pediatr</em> 161 Suppl: S127–31. doi:<a href="https://doi.org/10.1007/s00431-002-1064-z">10.1007/s00431-002-1064-z</a>.</p>
</div>
<div>
<p>Black, Steven B, H R Shinefield, S Ling, J Hansen, Bruce Fireman, D Spring, J Noyes, et al. 2002. “Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.” <em>Pediatr Infect Dis J</em> 21 (9): 810–15. doi:<a href="https://doi.org/10.1097/01.inf.0000027926.99356.4c">10.1097/01.inf.0000027926.99356.4c</a>.</p>
</div>
<div>
<p>Blank, Patricia R., and Thomas D. Szucs. 2012. “Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.” <em>Vaccine</em> 30 (28): 4267–75. doi:<a href="https://doi.org/10.1016/j.vaccine.2012.04.028">10.1016/j.vaccine.2012.04.028</a>.</p>
</div>
<div>
<p>Blank, Sarah J, David J Grindler, Kristine A Schulz, David L Witsell, and Judith E C Lieu. 2014. “Caregiver Quality of Life Is Related to Severity of Otitis Media in Children.” <em>Otolaryngology-Head and Neck Surgery</em> 151 (2). NIH Public Access: 348–53. doi:<a href="https://doi.org/10.1177/0194599814531912">10.1177/0194599814531912</a>.</p>
</div>
<div>
<p>Block, Stan L., James Hedrick, Christopher J. Harrison, Ron Tyler, Alan Smith, Rebecca Findlay, and Eileen Keegan. 2004. “Community-Wide Vaccination with the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media.” <em>The Pediatric Infectious Disease Journal</em> 23 (9): 829–33. doi:<a href="https://doi.org/10.1097/01.inf.0000136868.91756.80">10.1097/01.inf.0000136868.91756.80</a>.</p>
</div>
<div>
<p>Bluestone, C D, J S Stephenson, and L M Martin. 1992. “Ten-year review of otitis media pathogens.” <em>The Pediatric Infectious Disease Journal</em> 11 (8 Suppl): S7–11. doi:<a href="https://doi.org/10.1097/00006454-199208001-00002">10.1097/00006454-199208001-00002</a>.</p>
</div>
<div>
<p>Bright, R A, R M Moore, L L Jeng, C M Sharkness, S E Hamburger, and P M Hamilton. 1993. “The prevalence of tympanostomy tubes in children in the United States, 1988.” <em>American Journal of Public Health</em> 83 (7): 1026–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8328599 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1694786" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/8328599 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1694786</a>.</p>
</div>
<div>
<p>Browning, George G, Maroeska M Rovers, Ian Williamson, Jørgen Lous, and Martin J Burton. 2010. “Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.” <em>Cochrane Database of Systematic Reviews</em>, no. 10 (October). doi:<a href="https://doi.org/10.1002/14651858.CD001801.pub3">10.1002/14651858.CD001801.pub3</a>.</p>
</div>
<div>
<p>Bruhn, Christian A W, Stephen Hetterich, Cynthia Schuck-Paim, Esra Kürüm, Robert J Taylor, Roger Lustig, Eugene D Shapiro, Joshua L Warren, Lone Simonsen, and Daniel M Weinberger. 2017. “Estimating the population-level impact of vaccines using synthetic controls.” <em>Proceedings of the National Academy of Sciences</em> 114 (7): 1524–9. doi:<a href="https://doi.org/10.1073/pnas.1612833114">10.1073/pnas.1612833114</a>.</p>
</div>
<div>
<p>By, Åsa, Patrik Sobocki, Arne Forsgren, and Sven-Arne Silfverdal. 2012. “Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model.” <em>Clinical Therapeutics</em> 34 (1): 177–89. doi:<a href="https://doi.org/10.1016/j.clinthera.2011.12.007">10.1016/j.clinthera.2011.12.007</a>.</p>
</div>
<div>
<p>Byford, S, and J Raftery. 1998. “Economics notes: Perspectives in economic evaluation.” <em>BMJ</em> 316 (7143): 1529–30. doi:<a href="https://doi.org/10.1136/bmj.316.7143.1529">10.1136/bmj.316.7143.1529</a>.</p>
</div>
<div>
<p>Casey, Janet R, Diana G Adlowitz, and Michael E Pichichero. 2009. “New Patterns in the Otopathogens Causing Acute Otitis Media Six to Eight Years After Introduction of Pneumococcal Conjugate Vaccine.” <em>The Pediatric Infectious Disease Journal</em> 29 (November): 1. doi:<a href="https://doi.org/10.1097/INF.0b013e3181c1bc48">10.1097/INF.0b013e3181c1bc48</a>.</p>
</div>
<div>
<p>Casey, Janet R., and Michael E. Pichichero. 2004. “Changes in frequency and pathogens causing acute otitis media in 1995-2003.” <em>The Pediatric Infectious Disease Journal</em> 23 (9): 824–8. doi:<a href="https://doi.org/10.1097/01.inf.0000136871.51792.19">10.1097/01.inf.0000136871.51792.19</a>.</p>
</div>
<div>
<p>Castiglia, Paolo, Lorenzo Pradelli, Stefano Castagna, Veronica Freguglia, Giorgio Palù, and Susanna Esposito. 2017. “Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy.” <em>Human Vaccines &amp; Immunotherapeutics</em> 13 (10). Taylor &amp; Francis: 2307–15. doi:<a href="https://doi.org/10.1080/21645515.2017.1343773">10.1080/21645515.2017.1343773</a>.</p>
</div>
<div>
<p>Cecil, R. L. 1918. “RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN.” <em>Journal of Experimental Medicine</em> 28 (1): 19–41. doi:<a href="https://doi.org/10.1084/jem.28.1.19">10.1084/jem.28.1.19</a>.</p>
</div>
<div>
<p>Chandran, Aruna, Hadley Herbert, Derek Misurski, and Mathuram Santosham. 2011. “Long-term sequelae of childhood bacterial meningitis: an underappreciated problem.” <em>The Pediatric Infectious Disease Journal</em> 30 (1): 3–6. doi:<a href="https://doi.org/10.1097/INF.0b013e3181ef25f7">10.1097/INF.0b013e3181ef25f7</a>.</p>
</div>
<div>
<p>Chen, Yi-Jen, Yu-Chia Hsieh, Yhu-Chering Huang, and Cheng-Hsun Chiu. 2013. “Clinical manifestations and microbiology of acute otitis media with spontaneous otorrhea in children.” <em>Journal of Microbiology, Immunology and Infection</em> 46 (5). Elsevier Taiwan LLC: 382–88. doi:<a href="https://doi.org/10.1016/j.jmii.2013.04.001">10.1016/j.jmii.2013.04.001</a>.</p>
</div>
<div>
<p>Cherian, T, EK Mulholland, JB Carlin, and H Ostensen. 2004. “Standardized Interpretation of Paediatric Chest Radiographs for the Diagnosis of Pneumonia in Epidemiological Studies Variability in the Interpretation of Chest Radiographs ! Standardized Method for Identifying Radiological Pneumonia Would Facilitate Read.” <em>Bulletin of the World Health Organisation</em> 83 (5): 353–59.</p>
</div>
<div>
<p>Chonmaitree, Tasnee, Rocio Trujillo, Kristofer Jennings, Pedro Alvarez-Fernandez, Janak A Patel, Michael J Loeffelholz, Johanna Nokso-Koivisto, et al. 2016. “Acute Otitis Media and Other Complications of Viral Respiratory Infection.” <em>PEDIATRICS</em> 137 (4): e20153555–e20153555. doi:<a href="https://doi.org/10.1542/peds.2015-3555">10.1542/peds.2015-3555</a>.</p>
</div>
<div>
<p>Chuck, Anderson W., Philip Jacobs, Gregory Tyrell, and James D. Kellner. 2010. “Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines.” <em>Vaccine</em> 28: 5485–90. doi:<a href="https://doi.org/10.1016/j.vaccine.2010.05.058">10.1016/j.vaccine.2010.05.058</a>.</p>
</div>
<div>
<p>Cilloniz, Catia, Ignacio Martin-Loeches, Carolina Garcia-Vidal, Alicia San Jose, and Antoni Torres. 2016. “Microbial etiology of pneumonia: Epidemiology, diagnosis and resistance patterns.” <em>International Journal of Molecular Sciences</em> 17 (12). doi:<a href="https://doi.org/10.3390/ijms17122120">10.3390/ijms17122120</a>.</p>
</div>
<div>
<p>CLAESSON, BO A., BIRGER TROLLFORS, INGER BROLIN, MARTA GRANSTRÖM, JØRGEN HENRICHSEN, ULF JODAL, PER JUTO, et al. 1989. “Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.” <em>The Pediatric Infectious Disease Journal</em> 8 (12): 856–61. doi:<a href="https://doi.org/10.1097/00006454-198912000-00006">10.1097/00006454-198912000-00006</a>.</p>
</div>
<div>
<p>Claxton, Karl, Mike Paulden, Hugh Gravelle, Werner Brouwer, and Anthony J. Culyer. 2011. “Discounting and decision making in the economic evaluation of health-care technologies.” <em>Health Economics</em> 20 (1): 2–15. doi:<a href="https://doi.org/10.1002/hec.1612">10.1002/hec.1612</a>.</p>
</div>
<div>
<p>co-operation, Organisation for economic, and development. 2013. “PF3 . 2 : Enrolment in childcare and pre-schools.” <em>Social Policies and Data, OECD Family Database</em>, 3–8. <a href="http://www.oecd.org/social/soc/oecdfamilydatabase.htm" class="uri">http://www.oecd.org/social/soc/oecdfamilydatabase.htm</a>.</p>
</div>
<div>
<p>Coker, Tumaini R, Linda S Chan, Sydne J Newberry, Mary Ann Limbos, Marika J Suttorp, Paul G Shekelle, and Glenn S Takata. 2010. “Diagnosis, Microbial Epidemiology, and Antibiotic Treatment of Acute Otitis Media in Children.” <em>JAMA</em> 304 (19): 2161. doi:<a href="https://doi.org/10.1001/jama.2010.1651">10.1001/jama.2010.1651</a>.</p>
</div>
<div>
<p>Cook, Richard J. (Richard John), and Jerald F. Lawless. 2007. <em>The Statistical Analysis of Recurrent Events</em>. Edited by M Gail, K Krickeberg, J Sarmet, A Tsiatis, and W Wong. New York: Springer Science + Business Media.</p>
</div>
<div>
<p>Coyte, P C, Ruth Croxford, C V Asche, T To, W Feldman, and J Friedberg. 2001. “Physician and population determinants of rates of middle-ear surgery in Ontario.” <em>JAMA</em> 286 (17): 2128–35. doi:<a href="https://doi.org/10.1001/jama.286.17.2128">10.1001/jama.286.17.2128</a>.</p>
</div>
<div>
<p>Cullen, Karen A, Margaret J Hall, and Aleksandr Golosinskiy. 2009. “Ambulatory surgery in the United States, 2006.” <em>National Health Statistics Reports</em>, no. 11 (January): 1–25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19294964" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/19294964</a>.</p>
</div>
<div>
<p>Cutts, Felicity T, S M Zaman, Godwin C Enwere, S Jaffar, O S Levine, J B Okoko, C Oluwalana, et al. 2005. “Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.” <em>Lancet</em> 365 (9465): 1139–46. doi:<a href="https://doi.org/10.1016/s0140-6736(05)71876-6">10.1016/s0140-6736(05)71876-6</a>.</p>
</div>
<div>
<p>Dagan, Ron, M Sikuler-Cohen, O Zamir, J Janco, Noga Givon-Lavi, and D Fraser. 2001. “Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.” <em>Pediatr Infect Dis J</em> 20 (10): 951–58. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11642629" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/11642629</a>.</p>
</div>
<div>
<p>Davies, John A. V. 1937. “The Response of Infants to Inoculation with Type I Pneumococcus Carbohydrate.” <em>The Journal of Immunology</em>.</p>
</div>
<div>
<p>De Wals, Philippe, Steven Black, Ray Borrow, and David Pearce. 2009. “Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model.” <em>Clinical Therapeutics</em> 31 (10). Excerpta Medica Inc: 2152–69. doi:<a href="https://doi.org/10.1016/j.clinthera.2009.10.014">10.1016/j.clinthera.2009.10.014</a>.</p>
</div>
<div>
<p>Deibel, RH, and HW Seeley. 1974. “Family II: Streptococcuceae.” In <em>Bergey’s Manual of Determinative Bacteriology</em>, edited by R. E. Buchanan and N. E. Gibbons, 8th ed., 490–517. Baltimore: The William; Wilkins Co.</p>
</div>
<div>
<p>Delgleize, Emmanuelle, Oscar Leeuwenkamp, Eleni Theodorou, and Nicolas Van de Velde. 2016. “Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.” <em>BMJ Open</em> 6 (11): e010776. doi:<a href="https://doi.org/10.1136/bmjopen-2015-010776">10.1136/bmjopen-2015-010776</a>.</p>
</div>
<div>
<p>Desai, Shalini N, James D Kellner, and Derek Drummond. 2002. “Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada.” <em>The Pediatric Infectious Disease Journal</em> 21 (4): 348–50. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12075770" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/12075770</a>.</p>
</div>
<div>
<p>Devine, V. T., J. M. Jefferies, S. C. Clarke, and S. N. Faust. 2015. “Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.” <em>Journal of Immunology Research</em> 2015: 1–8. doi:<a href="https://doi.org/10.1155/2015/394368">10.1155/2015/394368</a>.</p>
</div>
<div>
<p>Díez-Domingo, Javier, Manuel Ridao-López, M Victoria Gutiérrez-Gimeno, Joan Puig-Barberá, Jose a Lluch-Rodrigo, and Eliseo Pastor-Villalba. 2011. “Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).” <em>Vaccine</em> 29 (52). Elsevier Ltd: 9640–8. doi:<a href="https://doi.org/10.1016/j.vaccine.2011.10.038">10.1016/j.vaccine.2011.10.038</a>.</p>
</div>
<div>
<p>Djurhuus, Bjarki Ditlev Ditlev, Axel Skytthe, Kaare Christensen, and Christian Emil Emil Faber. 2014. “Increasing rate of middle ear ventilation tube insertion in children in Denmark.” <em>International Journal of Pediatric Otorhinolaryngology</em> 78 (9): 1541–4. doi:<a href="https://doi.org/10.1016/j.ijporl.2014.06.034">10.1016/j.ijporl.2014.06.034</a>.</p>
</div>
<div>
<p>Dochez, A Lz, and O T Avery. 1917. “The elaboration of specific soluble substance by pneumococcus during growth.” <em>The Journal of Experimental Medicine</em>. doi:<a href="https://doi.org/10.1084/jem.26.4.477">10.1084/jem.26.4.477</a>.</p>
</div>
<div>
<p>Dowling, John N, Paul R Sheehe, and Harry A Feldman. 1971. “Pharyngeal pneumococcal acquisitions in ‘normal’ families: a longitudinal study.” <em>The Journal of Infectious Diseases</em> 124 (1): 9–17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/4401272" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/4401272</a>.</p>
</div>
<div>
<p>Drijkoningen, J J C, and G G U Rohde. 2014. “Pneumococcal infection in adults: burden of disease.” <em>Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases</em> 20 Suppl 5 (May): 45–51. doi:<a href="https://doi.org/10.1111/1469-0691.12461">10.1111/1469-0691.12461</a>.</p>
</div>
<div>
<p>Durando, Paolo, Pietro Crovari, Filippo Ansaldi, Laura Sticchi, Camilla Sticchi, Valter Turello, Lorenzo Marensi, Raffaella Giacchino, Anna Timitilli, and Roberto Carloni. 2009. “Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy.” <em>Vaccine</em> 27 (25-26): 3459–62. doi:<a href="https://doi.org/10.1016/j.vaccine.2009.01.052">10.1016/j.vaccine.2009.01.052</a>.</p>
</div>
<div>
<p>Dvorzak, Michaela, and Helga Wagner. 2016. <em>Pogit: Bayesian Variable Selection for a Poisson-Logistic Model</em>. <a href="https://CRAN.R-project.org/package=pogit" class="uri">https://CRAN.R-project.org/package=pogit</a>.</p>
</div>
<div>
<p>Earnshaw, Stephanie R, Cheryl L McDade, Giovanni Zanotti, Raymond A Farkouh, and David Strutton. 2012. “Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.” <em>BMC Infectious Diseases</em> 12 (1): 101. doi:<a href="https://doi.org/10.1186/1471-2334-12-101">10.1186/1471-2334-12-101</a>.</p>
</div>
<div>
<p>Ekwurzel, G M, J S Simmons, L I Dublin, and L D Felton. 1938. “Studies on immunizing substances in pneumococci. VIII. Report on field tests to determine the prophylactic value of a pneumococcus antigen.” <em>Public Health Rep</em> 53 (42): 1877–93.</p>
</div>
<div>
<p>Elemraid, Mohamed A., Andrew D. Sails, Gary J.A. Eltringham, John D. Perry, Stephen P. Rushton, David A. Spencer, Matthew F. Thomas, et al. 2013. “Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine.” <em>European Respiratory Journal</em> 42 (6): 1595–1603. doi:<a href="https://doi.org/10.1183/09031936.00199112">10.1183/09031936.00199112</a>.</p>
</div>
<div>
<p>Eskola, J, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, et al. 2001. “Efficacy of a pneumococcal conjugate vaccine against acute otitis media.” <em>N Engl J Med</em> 344 (6): 403–9. doi:<a href="https://doi.org/10.1056/nejm200102083440602">10.1056/nejm200102083440602</a>.</p>
</div>
<div>
<p>Esposito, Susanna, Alessandro Lizioli, Annalisa Lastrico, Enrica Begliatti, Alessandro Rognoni, Claudia Tagliabue, Laura Cesati, Vittorio Carreri, and Nicola Principi. 2007. “Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.” <em>Respiratory Research</em> 8 (January): 12. doi:<a href="https://doi.org/10.1186/1465-9921-8-12">10.1186/1465-9921-8-12</a>.</p>
</div>
<div>
<p>Eurostat. 2018. “Employment statistics.” <a href="https://ec.europa.eu/eurostat/statistics-explained/index.php/Employment{\_}statistics" class="uri">https://ec.europa.eu/eurostat/statistics-explained/index.php/Employment{\_}statistics</a>.</p>
</div>
<div>
<p>Eythorsson, Elias, Samuel Sigurdsson, Birgir Hrafnkelsson, Helga Erlendsdóttir, Ásgeir Haraldsson, and Karl G Kristinsson. 2018. “Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study.” <em>BMC Infectious Diseases</em> 18 (1). BMC Infectious Diseases: 505. doi:<a href="https://doi.org/10.1186/s12879-018-3416-y">10.1186/s12879-018-3416-y</a>.</p>
</div>
<div>
<p>Falster, Kathleen, Deborah Randall, Emily Banks, Sandra Eades, Hasantha Gunasekera, Jennifer Reath, and Louisa Jorm. 2013. “Inequalities in ventilation tube insertion procedures between Aboriginal and non-Aboriginal children in New South Wales, Australia: a data linkage study.” <em>BMJ Open</em> 3 (11): e003807. doi:<a href="https://doi.org/10.1136/bmjopen-2013-003807">10.1136/bmjopen-2013-003807</a>.</p>
</div>
<div>
<p>Feikin, Daniel R, Anne Schuchat, Margarette Kolczak, Nancy L Barrett, Lee H Harrison, Lewis Lefkowitz, Allison McGeer, et al. 2000. “Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.” <em>American Journal of Public Health</em> 90 (2): 223–29. doi:<a href="https://doi.org/10.1097/00006454-200011000-00030">10.1097/00006454-200011000-00030</a>.</p>
</div>
<div>
<p>Feikin, Daniel R., Laura L. Hammitt, David R. Murdoch, Katherine L. O’Brien, and J. Anthony G. Scott. 2017. “The Enduring Challenge of Determining Pneumonia Etiology in Children: Considerations for Future Research Priorities.” <em>Clinical Infectious Diseases</em> 64 (suppl_3): S188–S196. doi:<a href="https://doi.org/10.1093/cid/cix143">10.1093/cid/cix143</a>.</p>
</div>
<div>
<p>Finland, M. 1931. “SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA: I. CASES RECEIVING NO SERUM THERAPY.” <em>Journal of Experimental Medicine</em> 54 (5): 637–52. doi:<a href="https://doi.org/10.1084/jem.54.5.637">10.1084/jem.54.5.637</a>.</p>
</div>
<div>
<p>Finnbogadóttir, Anna Freyja, Hannes Petersen, Þröstur Laxdal, Fridrik Gudbrandsson, Þórólfur Gudnason, and Ásgeir Haraldsson. 2009. “An increasing incidence of mastoiditis in children in Iceland.” <em>Scandinavian Journal of Infectious Diseases</em> 41 (2): 95–98. doi:<a href="https://doi.org/10.1080/00365540802593461">10.1080/00365540802593461</a>.</p>
</div>
<div>
<p>Fireman, Bruce, Steven B Black, Henry R Shinefield, Janelle Lee, Edwin Lewis, and Paula Ray. 2003. “Impact of the pneumococcal conjugate vaccine on otitis media.” 1. 2003/01/25. Vol. 22. The Pediatric infectious disease journal. doi:<a href="https://doi.org/10.1097/00006454-200301000-00006">10.1097/00006454-200301000-00006</a>.</p>
</div>
<div>
<p>Florentzson, Rut, and Caterina Finizia. 2012. “Transmyringeal ventilation tube treatment: a 10-year cohort study.” <em>International Journal of Pediatric Otorhinolaryngology</em> 76 (8). Elsevier Ireland Ltd: 1117–22. doi:<a href="https://doi.org/10.1016/j.ijporl.2012.04.013">10.1016/j.ijporl.2012.04.013</a>.</p>
</div>
<div>
<p>Fortanier, Alexandre C, Roderick P Venekamp, Marieke L A de Hoog, Cuno S P M Uiterwaal, Anne C van der Gugten, Cornelis K van der Ent, Arno W Hoes, and Anne G M Schilder. 2015. “Parent-Reported Symptoms of Acute Otitis Media during the First Year of Life: What Is beneath the Surface?” Edited by Herminia de Lencastre. <em>PLOS ONE</em> 10 (4). Public Library of Science: e0121572. doi:<a href="https://doi.org/10.1371/journal.pone.0121572">10.1371/journal.pone.0121572</a>.</p>
</div>
<div>
<p>Francis, T, and W S Tillett. 1930. “Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide.” <em>The Journal of Experimental Medicine</em>. doi:<a href="https://doi.org/10.1084/jem.52.4.573">10.1084/jem.52.4.573</a>.</p>
</div>
<div>
<p>Gefenaite, G, M J Bijlsma, H J Bos, and E Hak. 2014. “Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children ? Analysis of 2002 to 2013 data.” <em>Eurosurveillance</em> 19 (44): 20948. doi:<a href="https://doi.org/10.2807/1560-7917.ES2014.19.44.20948">10.2807/1560-7917.ES2014.19.44.20948</a>.</p>
</div>
<div>
<p>Gendrel, D., J. Raymond, F. Moulin, J. L. Iniguez, S. Ravilly, F. Habib, P. Lebon, and G. Kalifa. 1997. “Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.” <em>European Journal of Clinical Microbiology &amp; Infectious Diseases</em> 16 (5): 388–91. doi:<a href="https://doi.org/10.1007/BF01726370">10.1007/BF01726370</a>.</p>
</div>
<div>
<p>Geno, K. Aaron, Gwendolyn L. Gilbert, Joon Young Song, Ian C. Skovsted, Keith P. Klugman, Christopher Jones, Helle B. Konradsen, and Moon H. Nahm. 2015. “Pneumococcal Capsules and Their Types: Past, Present, and Future.” <em>Clinical Microbiology Reviews</em> 28 (3): 871–99. doi:<a href="https://doi.org/10.1128/CMR.00024-15">10.1128/CMR.00024-15</a>.</p>
</div>
<div>
<p>Gilani, Zunera, Yuenting D. Kwong, Orin S. Levine, Maria Deloria-Knoll, J. Anthony G Scott, Katherine L. O’Brien, and Daniel R. Feikin. 2012. “A Literature Review and Survey of Childhood Pneumonia Etiology Studies: 2000–2010.” <em>Clinical Infectious Diseases</em> 54 (suppl_2): S102–S108. doi:<a href="https://doi.org/10.1093/cid/cir1053">10.1093/cid/cir1053</a>.</p>
</div>
<div>
<p>Gisselsson-Solen, Marie. 2017. “Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination; A National Observational Study.” <em>The Pediatric Infectious Disease Journal</em> 36 (11): 1. doi:<a href="https://doi.org/10.1097/INF.0000000000001654">10.1097/INF.0000000000001654</a>.</p>
</div>
<div>
<p>Glezen, W. Paul, and Floyd W. Denny. 1973. “Epidemiology of Acute Lower Respiratory Disease in Children.” <em>New England Journal of Medicine</em> 288 (10): 498–505. doi:<a href="https://doi.org/10.1056/NEJM197303082881005">10.1056/NEJM197303082881005</a>.</p>
</div>
<div>
<p>Gouveia, Miguel, Francesca Fiorentino, Gonçalo Jesus, João Costa, and Margarida Borges. 2017. “Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal.” <em>The Pediatric Infectious Disease Journal</em> 36 (8): 782–87. doi:<a href="https://doi.org/10.1097/INF.0000000000001587">10.1097/INF.0000000000001587</a>.</p>
</div>
<div>
<p>Gram, Christian. 1884. “Ueber die isolierte Fabung der Schizomyceten in Schnitt und Trockenpraparaten.” <em>Fortschritte Der Medicin</em> 2: 185–89.</p>
</div>
<div>
<p>Gray, Alastair M, Philip M Clarke, Jane L Wolstenholme, and Sarah Wordsworth. 2011. <em>Applied Methods of Cost-effectiveness Analysis in Health Care</em>. New York: Oxford University Press.</p>
</div>
<div>
<p>Gribben, Barry, Lesley J Salkeld, Simon Hoare, and Hannah F Jones. 2012. “The incidence of acute otitis media in New Zealand children under five years of age in the primary care setting.” <em>Journal of Primary Health Care</em> 4 (3): 205–12. <a href="http://www.ncbi.nlm.nih.gov/pubmed/22946068" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/22946068</a>.</p>
</div>
<div>
<p>Grijalva, C. G., K. A. Poehling, J. P. Nuorti, Y. Zhu, S. W. Martin, K. M. Edwards, and M. R. Griffin. 2006. “National Impact of Universal Childhood Immunization With Pneumococcal Conjugate Vaccine on Outpatient Medical Care Visits in the United States.” <em>PEDIATRICS</em> 118 (3): 865–73. doi:<a href="https://doi.org/10.1542/peds.2006-0492">10.1542/peds.2006-0492</a>.</p>
</div>
<div>
<p>Grijalva, Carlos G, J Pekka Nuorti, and Marie R Griffin. 2009. “Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.” <em>JAMA : The Journal of the American Medical Association</em> 302 (7): 758–66. doi:<a href="https://doi.org/10.1001/jama.2009.1163">10.1001/jama.2009.1163</a>.</p>
</div>
<div>
<p>Groth, Anita, Frida Enoksson, Ann Hermansson, Malou Hultcrantz, Joacim Stalfors, and Karin Stenfeldt. 2011. “Acute mastoiditis in children in Sweden 1993-2007-No increase after new guidelines.” <em>International Journal of Pediatric Otorhinolaryngology</em> 75 (12): 1496–1501. doi:<a href="https://doi.org/10.1016/j.ijporl.2011.08.015">10.1016/j.ijporl.2011.08.015</a>.</p>
</div>
<div>
<p>Groth, Christina, Reimar W Thomsen, and Therese Ovesen. 2015. “Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study.” <em>BMJ Open</em> 5 (6). BMJ Group: e007151. doi:<a href="https://doi.org/10.1136/bmjopen-2014-007151">10.1136/bmjopen-2014-007151</a>.</p>
</div>
<div>
<p>Gudnason, Thorolfur, Birgir Hrafnkelsson, Brynja Laxdal, and Karl G. Kristinsson. 2013. “Does hygiene intervention at day care centres reduce infectious illnesses in children? An intervention cohort study.” <em>Scandinavian Journal of Infectious Diseases</em> 45 (5): 397–403. doi:<a href="https://doi.org/10.3109/00365548.2012.749424">10.3109/00365548.2012.749424</a>.</p>
</div>
<div>
<p>Haapkylä, Johanna, Gunnhild Karevold, Kari Jorunn Kværner, and Anne Pitkäranta. 2008. “Trends in otitis media surgery: A decrease in adenoidectomy.” <em>International Journal of Pediatric Otorhinolaryngology</em> 72 (8): 1207–13. doi:<a href="https://doi.org/10.1016/j.ijporl.2008.04.012">10.1016/j.ijporl.2008.04.012</a>.</p>
</div>
<div>
<p>Habib, Maha, Barbara D. Porter, and Catherine Satzke. 2014. “Capsular Serotyping of &lt;em&gt;Streptococcus pneumoniae&lt;/em&gt; Using the Quellung Reaction.” <em>Journal of Visualized Experiments</em>, no. 84 (February). doi:<a href="https://doi.org/10.3791/51208">10.3791/51208</a>.</p>
</div>
<div>
<p>Hadley, Jack. 2003. “Sicker and Poorer—The Consequences of Being Uninsured: A Review of the Research on the Relationship between Health Insurance, Medical Care Use, Health, Work, and Income.” <em>Medical Care Research and Review</em> 60 (2_suppl): 3S–75S. doi:<a href="https://doi.org/10.1177/1077558703254101">10.1177/1077558703254101</a>.</p>
</div>
<div>
<p>Halloran, M. Elizabeth, Ira M. Longini, and Claudio J. Struchiner. 2010. <em>Design and Analysis of Vaccine Studies</em>. Statistics for Biology and Health. New York, NY: Springer New York. doi:<a href="https://doi.org/10.1007/978-0-387-68636-3">10.1007/978-0-387-68636-3</a>.</p>
</div>
<div>
<p>Hansen, John, Steven Black, Henry Shinefield, Thomas Cherian, Jane Benson, Bruce Fireman, Edwin Lewis, Paula Ray, and Janelle Lee. 2006. “Effectiveness of Heptavalent Pneumococcal Conjugate Vaccine in Children Younger Than 5 Years of Age for Prevention of Pneumonia.” <em>The Pediatric Infectious Disease Journal</em> 25 (9): 779–81. doi:<a href="https://doi.org/10.1097/01.inf.0000232706.35674.2f">10.1097/01.inf.0000232706.35674.2f</a>.</p>
</div>
<div>
<p>Harboe, Zitta B, Reimar W Thomsen, Anders Riis, Palle Valentiner-Branth, Jens Jørgen Christensen, Lotte Lambertsen, Karen A Krogfelt, Helle B Konradsen, and Thomas Benfield. 2009. “Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.” <em>PLoS Medicine</em> 6 (5). Public Library of Science: e1000081. doi:<a href="https://doi.org/10.1371/journal.pmed.1000081">10.1371/journal.pmed.1000081</a>.</p>
</div>
<div>
<p>Harboe, Zitta B, Palle Valentiner-Branth, Thomas Benfield, Jens Jørgen Christensen, Peter H Andersen, Michael Howitz, Karen A Krogfelt, Lotte Lambertsen, and Helle B Konradsen. 2010. “Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.” <em>Vaccine</em> 28 (14): 2642–7. doi:<a href="https://doi.org/10.1016/j.vaccine.2010.01.017">10.1016/j.vaccine.2010.01.017</a>.</p>
</div>
<div>
<p>Harrell, Jr., Frank E. 2018. <em>Rms: Regression Modeling Strategies</em>. <a href="https://CRAN.R-project.org/package=rms" class="uri">https://CRAN.R-project.org/package=rms</a>.</p>
</div>
<div>
<p>Heidelberger, M, and O T Avery. 1923. “THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.” <em>The Journal of Experimental Medicine</em>. doi:<a href="https://doi.org/10.1084/jem.40.3.301">10.1084/jem.40.3.301</a>.</p>
</div>
<div>
<p>Heikkinen, T, and T Chonmaitree. 2003. “Importance of respiratory viruses in acute otitis media.” <em>Clin Microbiol Rev</em> 16 (2): 230–41.</p>
</div>
<div>
<p>Herdman, Michael, Amanda Cole, Christopher K Hoyle, Victoria Coles, Stuart Carroll, and Nancy Devlin. 2016. “Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.” <em>Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research</em> 19 (2): 255–66. doi:<a href="https://doi.org/10.1016/j.jval.2015.11.003">10.1016/j.jval.2015.11.003</a>.</p>
</div>
<div>
<p>Hoek, Albert Jan van, Nick Andrews, Pauline a. Waight, Robert George, and Elizabeth Miller. 2012. “Effect of serotype on focus and mortality of invasive pneumococcal disease: Coverage of different vaccines and insight into non-vaccine serotypes.” <em>PLoS ONE</em> 7 (7). doi:<a href="https://doi.org/10.1371/journal.pone.0039150">10.1371/journal.pone.0039150</a>.</p>
</div>
<div>
<p>Hoek, Albert Jan van, Yoon Hong Choi, Caroline Trotter, Elizabeth Miller, and Mark Jit. 2012. “The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England.” <em>Vaccine</em> 30 (50). Elsevier Ltd: 7205–13. doi:<a href="https://doi.org/10.1016/j.vaccine.2012.10.017">10.1016/j.vaccine.2012.10.017</a>.</p>
</div>
<div>
<p>Holubar, Marisa, Maria Christina Stavroulakis, Yvonne Maldonado, John P A Ioannidis, and Despina Contopoulos-Ioannidis. 2017. “Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.” <em>PLoS ONE</em> 12 (3): 1–22. doi:<a href="https://doi.org/10.1371/journal.pone.0172414">10.1371/journal.pone.0172414</a>.</p>
</div>
<div>
<p>Hoshino, Kazuhiko, Hiroshi Watanabe, Rinya Sugita, Norichika Asoh, Simon Angelo Ntabaguzi, Kiwao Watanabe, Kazunori Oishi, and Tsuyoshi Nagatake. 2002. “High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children.” <em>Journal of Clinical Microbiology</em> 40 (11): 4357–9. doi:<a href="https://doi.org/10.1128/JCM.40.11.4357">10.1128/JCM.40.11.4357</a>.</p>
</div>
<div>
<p>Howitz, Michael Frantz, Zitta Barrella Harboe, Helene Ingels, Palle Valentiner-Branth, Kåre Mølbak, and Bjarki Ditlev Djurhuus. 2017. “A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.” <em>Vaccine</em> 35 (43). Elsevier Ltd: 5858–63. doi:<a href="https://doi.org/10.1016/j.vaccine.2017.09.006">10.1016/j.vaccine.2017.09.006</a>.</p>
</div>
<div>
<p>Hsu, Heather E, Kathleen A Shutt, Matthew R Moore, Bernard W Beall, Nancy M Bennett, Allen S Craig, Monica M Farley, et al. 2009. “Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.” <em>The New England Journal of Medicine</em> 360 (3): 244–56. doi:<a href="https://doi.org/10.1056/NEJMoa0800836">10.1056/NEJMoa0800836</a>.</p>
</div>
<div>
<p>HUSSAIN, M., A. MELEGARO, R. G. PEBODY, R. GEORGE, W. J. EDMUNDS, R. TALUKDAR, S. A. MARTIN, A. EFSTRATIOU, and E. MILLER. 2005. “A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting.” <em>Epidemiology and Infection</em> 133 (05): 891. doi:<a href="https://doi.org/10.1017/S0950268805004012">10.1017/S0950268805004012</a>.</p>
</div>
<div>
<p>Isaacman, Daniel J, David R Strutton, Edward a Kalpas, Nathalie Horowicz-Mehler, Lee S Stern, Roman Casciano, and Vincent Ciuryla. 2008. “The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.” <em>Clinical Therapeutics</em> 30 (2): 341–57. doi:<a href="https://doi.org/10.1016/j.clinthera.2008.02.003">10.1016/j.clinthera.2008.02.003</a>.</p>
</div>
<div>
<p>Jain, Seema, Derek J. Williams, Sandra R. Arnold, Krow Ampofo, Anna M. Bramley, Carrie Reed, Chris Stockmann, et al. 2015. “Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children.” <em>New England Journal of Medicine</em> 372 (9): 835–45. doi:<a href="https://doi.org/10.1056/NEJMoa1405870">10.1056/NEJMoa1405870</a>.</p>
</div>
<div>
<p>Jandoc, Racquel, Andrea M. Burden, Muhammad Mamdani, Linda E. Lévesque, and Suzanne M. Cadarette. 2015. “Interrupted time series analysis in drug utilization research is increasing: Systematic review and recommendations.” In <em>Journal of Clinical Epidemiology</em>, 68:950–56. 8. doi:<a href="https://doi.org/10.1016/j.jclinepi.2014.12.018">10.1016/j.jclinepi.2014.12.018</a>.</p>
</div>
<div>
<p>Jardine, Andrew, Robert I. Menzies, Shelley L. Deeks, Mahomed S. Patel, and Peter B. McIntyre. 2009. “The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.” <em>The Pediatric Infectious Disease Journal</em> 28 (9): 761–5. doi:<a href="https://doi.org/10.1097/INF.0b013e31819e9bc5">10.1097/INF.0b013e31819e9bc5</a>.</p>
</div>
<div>
<p>Kastenbauer, S., and H.-W. Pfister. 2003. “Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases.” <em>Brain</em> 126 (5): 1015–25. doi:<a href="https://doi.org/10.1093/brain/awg113">10.1093/brain/awg113</a>.</p>
</div>
<div>
<p>Kaur, Ravinder, Matthew Morris, and Michael E. Pichichero. 2017. “Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.” <em>Pediatrics</em> 140 (3): e20170181. doi:<a href="https://doi.org/10.1542/peds.2017-0181">10.1542/peds.2017-0181</a>.</p>
</div>
<div>
<p>Keitel, K, G Alcoba, L Lacroix, S Manzano, a Galetto-Lacour, and a Gervaix. 2014. “Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.” <em>Swiss Medical Weekly</em> 144 (April): w13925. doi:<a href="https://doi.org/10.4414/smw.2014.13925">10.4414/smw.2014.13925</a>.</p>
</div>
<div>
<p>Keyhani, Salomeh, Lawrence C Kleinman, Michael Rothschild, Joseph M Bernstein, Rebecca Anderson, and Mark Chassin. 2008. “Overuse of tympanostomy tubes in New York metropolitan area: evidence from five hospital cohort.” <em>BMJ (Clinical Research Ed.)</em> 337 (5). British Medical Journal Publishing Group: a1607. doi:<a href="https://doi.org/10.1136/bmj.a1607">10.1136/bmj.a1607</a>.</p>
</div>
<div>
<p>Kilpi, T, Heidi Ahman, J Jokinen, K S Lankinen, A Palmu, H Savolainen, M Gronholm, et al. 2003. “Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate v.” <em>Clin Infect Dis</em> 37 (9): 1155–64. doi:<a href="https://doi.org/10.1086/378744">10.1086/378744</a>.</p>
</div>
<div>
<p>Kilpi, T.M., J. Jokinen, T. Puumalainen, H. Nieminen, E. Ruokokoski, H. Rinta-Kokko, M. Traskine, et al. 2018. “Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.” <em>Vaccine</em> 36 (39). The Authors: 5891–5901. doi:<a href="https://doi.org/10.1016/j.vaccine.2018.08.020">10.1016/j.vaccine.2018.08.020</a>.</p>
</div>
<div>
<p>Kim, Su Jin, Ji Hyun Chung, Ho Min Kang, and Seung Geun Yeo. 2013. “Clinical bacteriology of recurrent otitis media with effusion.” <em>Acta Oto-Laryngologica</em> 133 (11). Taylor &amp; Francis: 1133–41. doi:<a href="https://doi.org/10.3109/00016489.2013.816442">10.3109/00016489.2013.816442</a>.</p>
</div>
<div>
<p>Kim, Sun-young, and Sue J Goldie. 2008. “Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.” <em>PharmacoEconomics</em> 26 (3): 191–215. doi:<a href="https://doi.org/2634 [pii]">2634 [pii]</a>.</p>
</div>
<div>
<p>Kirkwood, BR, and JAC Sterne. 2003. <em>Essential medical statistics</em>. Edited by Fiona Goodgame. 2nd ed. Oxford: Blackwell Science. doi:<a href="https://doi.org/10.1002/sim.1961">10.1002/sim.1961</a>.</p>
</div>
<div>
<p>Klok, Rogier M, Rose-Marie Lindkvist, Mats Ekelund, Raymond a Farkouh, and David R Strutton. 2013. “Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden.” <em>Clinical Therapeutics</em> 35 (2). Elsevier Inc.: 119–34. doi:<a href="https://doi.org/10.1016/j.clinthera.2012.12.006">10.1016/j.clinthera.2012.12.006</a>.</p>
</div>
<div>
<p>Knerer, Gerhart, Afisi Ismaila, and David Pearce. 2012. “Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise.” <em>Journal of Medical Economics</em> 15 (1): 61–76. doi:<a href="https://doi.org/10.3111/13696998.2011.622323">10.3111/13696998.2011.622323</a>.</p>
</div>
<div>
<p>Kogan, M D, M D Overpeck, H J Hoffman, and M L Casselbrant. 2000. “Factors associated with tympanostomy tube insertion among preschool-aged children in the United States.” <em>American Journal of Public Health</em> 90 (2): 245–50. <a href="http://search.ebscohost.com/login.aspx?direct=true{\%}7B{\&amp;}{\%}7Ddb=rzh{\%}7B{\&amp;}{\%}7DAN=107110611{\%}7B{\&amp;}{\%}7Dsite=ehost-live{\%}7B{\&amp;}{\%}7Dscope=site http://www.ncbi.nlm.nih.gov/pubmed/10667186 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1446140 http://search.ebscoh" class="uri">http://search.ebscohost.com/login.aspx?direct=true{\%}7B{\&amp;}{\%}7Ddb=rzh{\%}7B{\&amp;}{\%}7DAN=107110611{\%}7B{\&amp;}{\%}7Dsite=ehost-live{\%}7B{\&amp;}{\%}7Dscope=site http://www.ncbi.nlm.nih.gov/pubmed/10667186 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1446140 http://search.ebscoh</a>.</p>
</div>
<div>
<p>Kuhlmann, Alexander, and J-Matthias Graf von der Schulenburg. 2017. “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.” <em>The European Journal of Health Economics</em> 18 (3). Springer Berlin Heidelberg: 273–92. doi:<a href="https://doi.org/10.1007/s10198-016-0770-9">10.1007/s10198-016-0770-9</a>.</p>
</div>
<div>
<p>Kvaerner, Kari J, Per Nafstad, and Jouni J K Jaakkola. 2002. “Otolaryngological surgery and upper respiratory tract infections in children: an epidemiological study.” <em>The Annals of Otology, Rhinology, and Laryngology</em> 111 (11): 1034–9. doi:<a href="https://doi.org/10.1177/000348940211101115">10.1177/000348940211101115</a>.</p>
</div>
<div>
<p>Ladhani, Shamez N., Mary P E Slack, Nick Andrews, Pauline a. Waight, Ray Borrow, and Elizabeth Miller. 2013. “Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.” <em>Emerging Infectious Diseases</em> 19 (1): 61–68. doi:<a href="https://doi.org/10.3201/eid1901.120741">10.3201/eid1901.120741</a>.</p>
</div>
<div>
<p>Lau, Wallis C Y, Macey Murray, Aisha El-Turki, Sonia Saxena, Shamez Ladhani, Paul Long, Mike Sharland, Ian C K Wong, and Yingfen Hsia. 2015. “Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.” <em>Vaccine</em> 33 (39): 5072–9. doi:<a href="https://doi.org/10.1016/j.vaccine.2015.08.022">10.1016/j.vaccine.2015.08.022</a>.</p>
</div>
<div>
<p>Le Polain de Waroux, Olivier, Stefan Flasche, David Prieto-Merino, and W John Edmunds. 2014. “Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis.” Edited by Hiroshi Nishiura. <em>PLoS ONE</em> 9 (1): e86136. doi:<a href="https://doi.org/10.1371/journal.pone.0086136">10.1371/journal.pone.0086136</a>.</p>
</div>
<div>
<p>Legood, Rosa, Pietro G Coen, Kyle Knox, Russell M Viner, Haitham El Bashir, Deborah Christie, Bharat C Patel, and Robert Booy. 2009. “Health related quality of life in survivors of pneumococcal meningitis.” <em>Acta Paediatrica</em> 98 (3): 543–47. doi:<a href="https://doi.org/10.1111/j.1651-2227.2008.01136.x">10.1111/j.1651-2227.2008.01136.x</a>.</p>
</div>
<div>
<p>Leino, Tuija, Kari Auranen, Jukka Jokinen, Maija Leinonen, Päivi Tervonen, and Aino K. Takala. 2001. “Pneumococcal carriage in children during their first two years: important role of family exposure.” <em>The Pediatric Infectious Disease Journal</em> 20 (11): 1022–7. doi:<a href="https://doi.org/10.1097/00006454-200111000-00004">10.1097/00006454-200111000-00004</a>.</p>
</div>
<div>
<p>Levine, Orin S., Katherine L. O’Brien, Maria Deloria-Knoll, David R. Murdoch, Daniel R. Feikin, A. N. DeLuca, Amanda J. Driscoll, et al. 2012. “The Pneumonia Etiology Research for Child Health Project: A 21st Century Childhood Pneumonia Etiology Study.” <em>Clinical Infectious Diseases</em> 54 (suppl 2): S93–S101. doi:<a href="https://doi.org/10.1093/cid/cir1052">10.1093/cid/cir1052</a>.</p>
</div>
<div>
<p>Lieberthal, A. S., A. E. Carroll, T. Chonmaitree, T. G. Ganiats, A. Hoberman, M. A. Jackson, M. D. Joffe, et al. 2013. “The Diagnosis and Management of Acute Otitis Media.” <em>PEDIATRICS</em> 131 (3): e964–e999. doi:<a href="https://doi.org/10.1542/peds.2012-3488">10.1542/peds.2012-3488</a>.</p>
</div>
<div>
<p>Liese, J. G., S. A. Silfverdal, C. Giaquinto, A. Carmona, J. H. Larcombe, J. Garcia-Sicilia, A. Fuat, et al. 2014. “Incidence and clinical presentation of acute otitis media in children aged &lt;6 years in European medical practices.” <em>Epidemiology and Infection</em> 142 (8). Cambridge University Press: 1778–88. doi:<a href="https://doi.org/10.1017/S0950268813002744">10.1017/S0950268813002744</a>.</p>
</div>
<div>
<p>Lin, D. Y., and L. J. Wei. 1989. “The Robust Inference for the Cox Proportional Hazards Model.” <em>Journal of the American Statistical Association</em> 84 (408): 1074–8. doi:<a href="https://doi.org/10.1080/01621459.1989.10478874">10.1080/01621459.1989.10478874</a>.</p>
</div>
<div>
<p>Lister, Frederick Spencer. 1916. “An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man.” <em>Publication of the South African Institute of Medical Research</em> 8: 231–87.</p>
</div>
<div>
<p>Lister, Frederick Spencer, and D Ordman. 1936. “The Epidemiology of Pneumonia on the Witwatersrand Goldfields and the Prevention of Pneumonia and Other Allied Acute Respiratory Diseases in Native Labourers in South Africa by Means of Vaccine.” <em>Journal of the American Medical Association</em> 106 (9): 733. doi:<a href="https://doi.org/10.1001/jama.1936.02770090069032">10.1001/jama.1936.02770090069032</a>.</p>
</div>
<div>
<p>Loo, Jennifer D, Laura Conklin, Katherine E Fleming-Dutra, Maria Deloria Knoll, Daniel E Park, Jennifer Kirk, David Goldblatt, Katherine L O’Brien, and Cynthia G Whitney. 2014. “Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.” <em>The Pediatric Infectious Disease Journal</em> 33 Suppl 2 (1). Wolters Kluwer Health: S161–71. doi:<a href="https://doi.org/10.1097/INF.0000000000000084">10.1097/INF.0000000000000084</a>.</p>
</div>
<div>
<p>Loo, Jennifer D., Laura Conklin, Katherine E. Fleming-Dutra, Maria Deloria Knoll, Daniel E. Park, Jennifer Kirk, David Goldblatt, et al. 2014. “Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.” <em>The Pediatric Infectious Disease Journal</em> 33 Suppl 2 (1): S140–51. doi:<a href="https://doi.org/10.1097/INF.0000000000000082">10.1097/INF.0000000000000082</a>.</p>
</div>
<div>
<p>Mackenzie, Grant. 2016. “The definition and classification of pneumonia.” <em>Pneumonia</em> 8 (1). Pneumonia: 14. doi:<a href="https://doi.org/10.1186/s41479-016-0012-z">10.1186/s41479-016-0012-z</a>.</p>
</div>
<div>
<p>Macleod, C M, Richard G Hodges, Michael Heidelberger, and W G Bernhard. 1945. “PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.” <em>The Journal of Experimental Medicine</em> 82 (6): 445–65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19871511 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2135567" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/19871511 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2135567</a>.</p>
</div>
<div>
<p>Maddigan, Sheri L., David H. Feeny, and Jeffrey A. Johnson. 2005. “Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.” <em>Quality of Life Research</em> 14 (5): 1311–20. doi:<a href="https://doi.org/10.1007/s11136-004-6640-4">10.1007/s11136-004-6640-4</a>.</p>
</div>
<div>
<p>Madhi, Shabir a, Philippe De Wals, Carlos G Grijalva, Keith Grimwood, Ronald Grossman, Naruhiko Ishiwada, Ping-Ing Lee, et al. 2012. “The Burden of Childhood Pneumonia in the Developed World.” <em>The Pediatric Infectious Disease Journal</em> 32 (3): 1. doi:<a href="https://doi.org/10.1097/INF.0b013e3182784b26">10.1097/INF.0b013e3182784b26</a>.</p>
</div>
<div>
<p>Magnus, Maria C, Didrik F Vestrheim, Wenche Nystad, Siri Eldevik Håberg, Hein Stigum, Stephanie J London, Marianne R A R Bergsaker, Dominique A Caugant, Ingeborg S Aaberge, and Per Nafstad. 2012. “Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.” <em>The Pediatric Infectious Disease Journal</em> 31 (9): 951–5. doi:<a href="https://doi.org/10.1097/INF.0b013e31825d2f76">10.1097/INF.0b013e31825d2f76</a>.</p>
</div>
<div>
<p>Mangen, Marie-Josée J, Susanne M. Huijts, Marc J M Bonten, and G. Ardine de Wit. 2017. “The impact of community-acquired pneumonia on the health-related quality-of-life in elderly.” <em>BMC Infectious Diseases</em> 17 (1). BMC Infectious Diseases: 208. doi:<a href="https://doi.org/10.1186/s12879-017-2302-3">10.1186/s12879-017-2302-3</a>.</p>
</div>
<div>
<p>Marchisio, Paola, Luigi Cantarutti, Miriam Sturkenboom, Silvia Girotto, Gino Picelli, Daniele Dona, Antonio Scamarcia, Marco Villa, Carlo Giaquinto, and Pedianet. 2012. “Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database.” <em>BMC Pediatrics</em> 12 (1). BMC Pediatrics: 185. doi:<a href="https://doi.org/10.1186/1471-2431-12-185">10.1186/1471-2431-12-185</a>.</p>
</div>
<div>
<p>Marom, Tal, Ofer Israel, Haim Gavriel, Jacob Pitaro, Ali Abo Baker, and Ephraim Eviatar. 2017. “Comparison of first year of life acute otitis media admissions before and after the 13-valent pneumococcal conjugate vaccine.” <em>International Journal of Pediatric Otorhinolaryngology</em> 97 (June). Elsevier: 251–56. doi:<a href="https://doi.org/10.1016/j.ijporl.2017.04.023">10.1016/j.ijporl.2017.04.023</a>.</p>
</div>
<div>
<p>Marom, Tal, Alai Tan, Gregg S. Wilkinson, Karen S. Pierson, Jean L. Freeman, and Tasnee Chonmaitree. 2014. “Trends in otitis media-related health care use in the United States, 2001-2011.” <em>JAMA Pediatrics</em> 168 (1). American Medical Association: 68–75. doi:<a href="https://doi.org/10.1001/jamapediatrics.2013.3924">10.1001/jamapediatrics.2013.3924</a>.</p>
</div>
<div>
<p>Mauskopf, Josephine, Baudouin Standaert, Mark P. Connolly, Anthony J. Culyer, Louis P. Garrison, Raymond Hutubessy, Mark Jit, Richard Pitman, Paul Revill, and Johan L. Severens. 2018. “Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report.” <em>Value in Health</em> 21 (10). Elsevier Inc.: 1133–49. doi:<a href="https://doi.org/10.1016/j.jval.2018.08.005">10.1016/j.jval.2018.08.005</a>.</p>
</div>
<div>
<p>Maynard, G D. 1913. “An enquiry into the etiology, manifestations and prevention of pneumonia amongst natives on the Rand recruited from tropical areas.” <em>Public South Afr Inst Med Res</em> 1 (0): 1–101.</p>
</div>
<div>
<p>Mäkelä, P H, M Leinonen, J Pukander, and P Karma. 1981. “A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.” <em>Reviews of Infectious Diseases</em> 3 Suppl: S124–32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6974386" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/6974386</a>.</p>
</div>
<div>
<p>Melegaro, A, and W.J. Edmunds. 2004. “Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.” <em>Vaccine</em> 22 (31-32): 4203–14. doi:<a href="https://doi.org/10.1016/j.vaccine.2004.05.003">10.1016/j.vaccine.2004.05.003</a>.</p>
</div>
<div>
<p>MELEGARO, A., N. J. GAY, and G. F. MEDLEY. 2004. “Estimating the transmission parameters of pneumococcal carriage in households.” <em>Epidemiology and Infection</em> 132 (3): 433–41. doi:<a href="https://doi.org/10.1017/S0950268804001980">10.1017/S0950268804001980</a>.</p>
</div>
<div>
<p>Monasta, Lorenzo, Luca Ronfani, Federico Marchetti, Marcella Montico, Liza Vecchi Brumatti, Alessandro Bavcar, Domenico Grasso, et al. 2012. “Burden of disease caused by otitis media: Systematic review and global estimates.” <em>PLoS ONE</em> 7 (4): e36226. doi:<a href="https://doi.org/10.1371/journal.pone.0036226">10.1371/journal.pone.0036226</a>.</p>
</div>
<div>
<p>Morrow, Adrienne, Philippe De Wals, Geneviève Petit, Maryse Guay, and Lonny James Erickson. 2007. “The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine.” <em>Canadian Journal of Infectious Diseases and Medical Microbiology</em> 18 (2): 121–27. doi:<a href="https://doi.org/10.1155/2007/713576">10.1155/2007/713576</a>.</p>
</div>
<div>
<p>Mosser, Jonathan F., Lindsay R. Grant, Eugene V. Millar, Robert C. Weatherholtz, Delois M. Jackson, Bernard Beall, Mariddie J. Craig, Raymond Reid, Mathuram Santosham, and Katherine L. O’Brien. 2014. “Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use.” <em>PLoS ONE</em> 9 (1): 3–10. doi:<a href="https://doi.org/10.1371/journal.pone.0079578">10.1371/journal.pone.0079578</a>.</p>
</div>
<div>
<p>Mufson, M A, and R J Stanek. 1999. “Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.” <em>The American Journal of Medicine</em> 107 (1A): 34S–43S. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10451007" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/10451007</a>.</p>
</div>
<div>
<p>Myint, Tin Tin Htar, Harish Madhava, Paul Balmer, Dina Christopoulou, Sepideh Attal, Damianos Menegas, Ralf Sprenger, and Eric Bonnet. 2013. “The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.” <em>Advances in Therapy</em> 30 (2): 127–51. doi:<a href="https://doi.org/10.1007/s12325-013-0007-6">10.1007/s12325-013-0007-6</a>.</p>
</div>
<div>
<p>Newall, A.T., J.F. Reyes, P. McIntyre, R. Menzies, P. Beutels, and J.G. Wood. 2016. “Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.” <em>Vaccine</em> 34 (3). Elsevier Ltd: 320–27. doi:<a href="https://doi.org/10.1016/j.vaccine.2015.11.053">10.1016/j.vaccine.2015.11.053</a>.</p>
</div>
<div>
<p>Newall, Anthony T., Prudence Creighton, David J. Philp, James G. Wood, and C. Raina MacIntyre. 2011. “The potential cost-effectiveness of infant pneumococcal vaccines in Australia.” <em>Vaccine</em> 29: 8077–85. doi:<a href="https://doi.org/10.1016/j.vaccine.2011.08.050">10.1016/j.vaccine.2011.08.050</a>.</p>
</div>
<div>
<p>Ngo, Chinh C., Helen M. Massa, Ruth B. Thornton, and Allan W. Cripps. 2016. “Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.” Edited by Sean Reid. <em>PloS One</em> 11 (3): e0150949. doi:<a href="https://doi.org/10.1371/journal.pone.0150949">10.1371/journal.pone.0150949</a>.</p>
</div>
<div>
<p>Nicholls, Thomas Rodger, Amanda Jane Leach, and Peter Stanley Morris. 2016. “The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.” <em>Vaccine</em> 34 (6). Elsevier Ltd: 703–13. doi:<a href="https://doi.org/10.1016/j.vaccine.2015.12.048">10.1016/j.vaccine.2015.12.048</a>.</p>
</div>
<div>
<p>Oostenbrink, Rianne, Henriëtte A Moll, and Marie-Louise Essink-Bot. 2002. “The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis.” <em>Journal of Clinical Epidemiology</em> 55 (8): 791–99. doi:<a href="https://doi.org/10.1016/S0895-4356(02)00448-1">10.1016/S0895-4356(02)00448-1</a>.</p>
</div>
<div>
<p>O’Brien, Katherine L, Lawrence H Moulton, Raymond Reid, Robert Weatherholtz, Jane Oski, Laura Brown, Gaurav Kumar, et al. 2003. “Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.” <em>Lancet</em> 362 (9381): 355–61. doi:<a href="https://doi.org/10.1016/S0140-6736(03)14022-6">10.1016/S0140-6736(03)14022-6</a>.</p>
</div>
<div>
<p>O’Brien, Katherine L., Angeline B David, Aruna Chandran, Lawrence H Moulton, Raymond Reid, Robert Weatherholtz, and Mathuram Santosham. 2008. “RANDOMIZED, CONTROLLED TRIAL EFFICACY OF PNEUMOCOCCAL CONJUGATE VACCINE AGAINST OTITIS MEDIA AMONG NAVAJO AND WHITE MOUNTAIN APACHE INFANTS.” <em>The Pediatric Infectious Disease Journal</em> 27 (1): 71–73. doi:<a href="https://doi.org/10.1097/INF.0b013e318159228f">10.1097/INF.0b013e318159228f</a>.</p>
</div>
<div>
<p>O’Brien, Katherine L., Lara J. Wolfson, James P. Watt, Emily Henkle, Maria Deloria-Knoll, Natalie McCall, Ellen Lee, et al. 2009. “Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.” <em>The Lancet</em> 374 (9693). Elsevier Ltd: 893–902. doi:<a href="https://doi.org/10.1016/S0140-6736(09)61204-6">10.1016/S0140-6736(09)61204-6</a>.</p>
</div>
<div>
<p>O’Brien, Megan A, Lisa A Prosser, Jack L Paradise, G Thomas Ray, Martin Kulldorff, Marcia Kurs-Lasky, Virginia L Hinrichsen, Jyotsna Mehta, D Kathleen Colborn, and Tracy A Lieu. 2009. “New vaccines against otitis media: projected benefits and cost-effectiveness.” <em>Pediatrics</em> 123 (6): 1452–63. doi:<a href="https://doi.org/10.1542/peds.2008-1482">10.1542/peds.2008-1482</a>.</p>
</div>
<div>
<p>PAISLEY, JOHN W., BRIAN A. LAUER, KENNETH MCINTOSH, MARY P. GLODE, JULIUS SCHACHTER, and ACAROL RUMACK. 1984. “Pathogens associated with acute lower respiratory tract infection in young children.” <em>The Pediatric Infectious Disease Journal</em> 3 (1): 14–19. doi:<a href="https://doi.org/10.1097/00006454-198401000-00005">10.1097/00006454-198401000-00005</a>.</p>
</div>
<div>
<p>Palmu, Arto A I, Jouko Verho, Jukka Jokinen, Pekka Karma, and Terhi M Kilpi. 2004. “The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children.” <em>The Pediatric Infectious Disease Journal</em> 23 (8): 732–38. doi:<a href="https://doi.org/10.1097/01.inf.0000133049.30299.5d">10.1097/01.inf.0000133049.30299.5d</a>.</p>
</div>
<div>
<p>Palmu, Arto A, Jukka Jokinen, Dorota Borys, Heta Nieminen, Esa Ruokokoski, Lotta Siira, Taneli Puumalainen, et al. 2013. “Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.” <em>Lancet</em> 381 (9862): 214–22. doi:<a href="https://doi.org/10.1016/s0140-6736(12)61854-6">10.1016/s0140-6736(12)61854-6</a>.</p>
</div>
<div>
<p>Palmu, Arto A, Jukka Jokinen, Heta Nieminen, Hanna Rinta-Kokko, Esa Ruokokoski, Taneli Puumalainen, Dorota Borys, et al. 2014. “Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.” <em>The Lancet Infectious Diseases</em> 14 (3). British Medical Journal Publishing Group: 205–12. doi:<a href="https://doi.org/10.1016/S1473-3099(13)70338-4">10.1016/S1473-3099(13)70338-4</a>.</p>
</div>
<div>
<p>Palmu, Arto A, Hanna Rinta-Kokko, Hanna Nohynek, J Pekka Nuorti, and Jukka Jokinen. 2017. “Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.” <em>The Pediatric Infectious Disease Journal</em> 37 (1): 1. doi:<a href="https://doi.org/10.1097/INF.0000000000001810">10.1097/INF.0000000000001810</a>.</p>
</div>
<div>
<p>Palmu, Arto, Jukka Jokinen, Heta Nieminen, Hanna Rinta-Kokko, Esa Ruokokoski, Taneli Puumalainen, Magali Traskine, et al. 2015. “Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-Randomized Trial.” <em>The Pediatric Infectious Disease Journal</em> 34 (11): 1230–5. doi:<a href="https://doi.org/http://dx.doi.org/10.1097/INF.0000000000000857">http://dx.doi.org/10.1097/INF.0000000000000857</a>.</p>
</div>
<div>
<p>Pasteur, Louis. 1881. “Note sur la maladie nouvelle provoquee par la salive d’un enfant mort de la rage.” 10. Vol. 2. Paris: I’Academie de Medicine. <a href="https://gallica.bnf.fr/ark:/12148/bpt6k408671n" class="uri">https://gallica.bnf.fr/ark:/12148/bpt6k408671n</a>.</p>
</div>
<div>
<p>Pedersen, Tine Marie, Anna-Rosa Cecilie Mora-Jensen, Johannes Waage, Hans Bisgaard, and Jakob Stokholm. 2016. “Incidence and Determinants of Ventilation Tubes in Denmark.” <em>PloS One</em> 11 (11): e0165657. doi:<a href="https://doi.org/10.1371/journal.pone.0165657">10.1371/journal.pone.0165657</a>.</p>
</div>
<div>
<p>Penfold, Robert B, and Fang Zhang. 2013. “Use of interrupted time series analysis in evaluating health care quality improvements.” <em>Academic Pediatrics</em> 13 (6 Suppl): S38–44. doi:<a href="https://doi.org/10.1016/j.acap.2013.08.002">10.1016/j.acap.2013.08.002</a>.</p>
</div>
<div>
<p>Petrou, Stavros, and Emil Kupek. 2009. “Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland.” <em>Medical Decision Making : An International Journal of the Society for Medical Decision Making</em> 29 (3): 291–303. doi:<a href="https://doi.org/10.1177/0272989X08327398">10.1177/0272989X08327398</a>.</p>
</div>
<div>
<p>Pichichero, Michael E., Janet R. Casey, Alejandro Hoberman, and Richard Schwartz. 2008. “Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.” <em>Clinical Pediatrics</em> 47 (9): 901–6. doi:<a href="https://doi.org/10.1177/0009922808319966">10.1177/0009922808319966</a>.</p>
</div>
<div>
<p>Pitman, Richard, David Fisman, Gregory S. Zaric, Maarten Postma, Mirjam Kretzschmar, John Edmunds, and Marc Brisson. 2012. “Dynamic Transmission Modeling.” <em>Medical Decision Making</em> 32 (5): 712–21. doi:<a href="https://doi.org/10.1177/0272989X12454578">10.1177/0272989X12454578</a>.</p>
</div>
<div>
<p>Poehling, K. A. 2004. “Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children.” <em>PEDIATRICS</em> 114 (3): 755–61. doi:<a href="https://doi.org/10.1542/peds.2003-0592-F">10.1542/peds.2003-0592-F</a>.</p>
</div>
<div>
<p>Poehling, Katherine A, Peter G Szilagyi, Carlos G Grijalva, Stacey W Martin, Bonnie LaFleur, Ed Mitchel, Richard D Barth, J Pekka Nuorti, and Marie R Griffin. 2007. “Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine.” <em>PEDIATRICS</em> 119 (4): 707–15. doi:<a href="https://doi.org/10.1542/peds.2006-2138">10.1542/peds.2006-2138</a>.</p>
</div>
<div>
<p>Prosser, Lisa A, G Thomas Ray, M. O’Brien, Ken Kleinman, Jeanne Santoli, and Tracy A Lieu. 2004. “Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine.” <em>PEDIATRICS</em> 113 (2): 283–90. doi:<a href="https://doi.org/10.1542/peds.113.2.283">10.1542/peds.113.2.283</a>.</p>
</div>
<div>
<p>Prymula, Roman, Pascal Peeters, Viktor Chrobok, Pavla Kriz, Elena Novakova, Eva Kaliskova, Igor Kohl, et al. 2006. “Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: A randomised double-blind efficacy study.” <em>Lancet</em> 367 (9512): 740–48. doi:<a href="https://doi.org/10.1016/S0140-6736(06)68304-9">10.1016/S0140-6736(06)68304-9</a>.</p>
</div>
<div>
<p>Pulido, Marifi, and Frank Sorvillo. 2010. “Declining invasive pneumococcal disease mortality in the United States, 1990-2005.” <em>Vaccine</em> 28 (4): 889–92. doi:<a href="https://doi.org/10.1016/j.vaccine.2009.10.121">10.1016/j.vaccine.2009.10.121</a>.</p>
</div>
<div>
<p>Pumarola, Felix, Josep Marès, Isabel Losada, Isabel Minguella, Fernando Moraga, David Tarragó, Ulla Aguilera, et al. 2013. “Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: Shifting pathogens in the post-pneumococcal conjugate vaccination era.” <em>International Journal of Pediatric Otorhinolaryngology</em> 77 (8): 1231–6. doi:<a href="https://doi.org/10.1016/j.ijporl.2013.04.002">10.1016/j.ijporl.2013.04.002</a>.</p>
</div>
<div>
<p>R Core Team. 2018. <em>R: A Language and Environment for Statistical Computing</em>. Vienna, Austria: R Foundation for Statistical Computing. <a href="https://www.R-project.org/" class="uri">https://www.R-project.org/</a>.</p>
</div>
<div>
<p>Ramakrishnan, Kalyanakrishnan, Rhonda A Sparks, and Wayne E Berryhill. 2007. “Diagnosis and treatment of otitis media.” <em>American Family Physician</em> 76 (11): 1650–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18092706" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/18092706</a>.</p>
</div>
<div>
<p>Ricketson, Leah J, Alberto Nettel-Aguirre, Otto G Vanderkooi, Kevin B Laupland, and James D Kellner. 2013. “Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance Study.” <em>PloS One</em> 8 (10): e71924. doi:<a href="https://doi.org/10.1371/journal.pone.0071924">10.1371/journal.pone.0071924</a>.</p>
</div>
<div>
<p>Robberstad, Bjarne, Carl R. Frostad, Per E. Akselsen, Kari J. Kværner, and Aud K H Berstad. 2011. “Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.” <em>Vaccine</em> 29: 8564–74. doi:<a href="https://doi.org/10.1016/j.vaccine.2011.09.025">10.1016/j.vaccine.2011.09.025</a>.</p>
</div>
<div>
<p>Rodrigues, C. M. C., and H. Groves. 2017. “Community-Acquired Pneumonia in Children: the Challenges of Microbiological Diagnosis.” Edited by Colleen Suzanne Kraft. <em>Journal of Clinical Microbiology</em> 56 (3): JCM.01318–17. doi:<a href="https://doi.org/10.1128/JCM.01318-17">10.1128/JCM.01318-17</a>.</p>
</div>
<div>
<p>Rosenfeld, Richard M., Jennifer J. Shin, Seth R. Schwartz, Robyn Coggins, Lisa Gagnon, Jesse M. Hackell, David Hoelting, et al. 2016. “Clinical Practice Guideline: Otitis Media with Effusion (Update).” <em>Otolaryngology–head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery</em> 154 (1 Suppl): S1–S41. doi:<a href="https://doi.org/10.1177/0194599815623467">10.1177/0194599815623467</a>.</p>
</div>
<div>
<p>Rozenbaum, M. H., P. Pechlivanoglou, T. S. Werf, J. R. Lo-Ten-Foe, M. J. Postma, and E. Hak. 2013. “The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.” <em>European Journal of Clinical Microbiology &amp; Infectious Diseases</em> 32 (3): 305–16. doi:<a href="https://doi.org/10.1007/s10096-012-1778-4">10.1007/s10096-012-1778-4</a>.</p>
</div>
<div>
<p>Rozenbaum, Mark H, Elisabeth a M Sanders, Albert Jan van Hoek, Angelique G S C Jansen, Arie van der Ende, Germie van den Dobbelsteen, Gerwin D Rodenburg, Eelko Hak, and Maarten J Postma. 2010. “Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.” <em>BMJ</em> 340 (jun02 1): c2509–c2509. doi:<a href="https://doi.org/10.1136/bmj.c2509">10.1136/bmj.c2509</a>.</p>
</div>
<div>
<p>Rubin, Jaime L., Lisa J. McGarry, David R. Strutton, Keith P. Klugman, Stephen I. Pelton, Kristen E. Gilmore, and Milton C. Weinstein. 2010. “Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States.” <em>Vaccine</em> 28 (48). Elsevier Ltd: 7634–43. doi:<a href="https://doi.org/10.1016/j.vaccine.2010.09.049">10.1016/j.vaccine.2010.09.049</a>.</p>
</div>
<div>
<p>Rudan, Igor, Katherine L O’Brien, Harish Nair, Li Liu, Evropi Theodoratou, Shamim Qazi, Ivana Lukšić, Christa L Fischer Walker, Robert E Black, and Harry Campbell. 2013. “Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.” <em>Journal of Global Health</em> 3 (1): 010401. doi:<a href="https://doi.org/10.7189/jogh.03.010401">10.7189/jogh.03.010401</a>.</p>
</div>
<div>
<p>Ruuskanen, O., H. Nohynek, T. Ziegler, R. Capeding, H. Rikalainen, P. Huovinen, and M. Leinonen. 1992. “Pneumonia in childhood: Etiology and response to antimicrobial therapy.” <em>European Journal of Clinical Microbiology &amp; Infectious Diseases</em> 11 (3): 217–23. doi:<a href="https://doi.org/10.1007/BF02098083">10.1007/BF02098083</a>.</p>
</div>
<div>
<p>Said, Maria a., Hope L. Johnson, Bareng a S Nonyane, Maria Deloria-Knoll, and Katherine L. O′Brien. 2013. “Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques.” Edited by Philip C. Hill. <em>PLoS ONE</em> 8 (4): e60273. doi:<a href="https://doi.org/10.1371/journal.pone.0060273">10.1371/journal.pone.0060273</a>.</p>
</div>
<div>
<p>Sanders, Gillian D., Peter J. Neumann, Anirban Basu, Dan W. Brock, David Feeny, Murray Krahn, Karen M. Kuntz, et al. 2016. “Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses.” <em>JAMA</em> 316 (10): 1093. doi:<a href="https://doi.org/10.1001/jama.2016.12195">10.1001/jama.2016.12195</a>.</p>
</div>
<div>
<p>Saokaew, Surasak, Ajaree Rayanakorn, David Bin-Chia Wu, and Nathorn Chaiyakunapruk. 2016. “Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.” <em>PharmacoEconomics</em> 34 (12). Springer International Publishing: 1211–25. doi:<a href="https://doi.org/10.1007/s40273-016-0439-3">10.1007/s40273-016-0439-3</a>.</p>
</div>
<div>
<p>Sarasoja, Ilona, Jukka Jokinen, Mika Lahdenkari, Terhi Kilpi, and Arto A. Palmu. 2013. “Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.” <em>The Pediatric Infectious Disease Journal</em> 32 (5): 517–20. doi:<a href="https://doi.org/10.1097/INF.0b013e31827c9bcc">10.1097/INF.0b013e31827c9bcc</a>.</p>
</div>
<div>
<p>Schiemann, O., and W. Casper. 1927. “Sind die spezifisch pracipitablen Substanzen der 3 Pneumokokkentypen Haptene?” <em>Zeitschrift Fur Hygiene Und Infektionskrankheiten</em>. doi:<a href="https://doi.org/10.1007/BF02176583">10.1007/BF02176583</a>.</p>
</div>
<div>
<p>Severens, Johan L., and Richard J. Milne. 2004. “Discounting health outcomes in economic evaluation: the ongoing debate.” <em>Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research</em> 7 (4): 397–401. doi:<a href="https://doi.org/10.1111/j.1524-4733.2004.74002.x">10.1111/j.1524-4733.2004.74002.x</a>.</p>
</div>
<div>
<p>Shioda, Kayoko, Cynthia Schuck-Paim, Robert J. Taylor, Roger Lustig, Lone Simonsen, Joshua L Warren, and Daniel M Weinberger. 2018. “Challenges in estimating the impact of vaccination with sparse data.” <em>Epidemiology (Cambridge, Mass.)</em> 4 (5): 1. doi:<a href="https://doi.org/10.1097/EDE.0000000000000938">10.1097/EDE.0000000000000938</a>.</p>
</div>
<div>
<p>Shiri, Tinevimbo, Samik Datta, Jason Madan, Alexander Tsertsvadze, Pamela Royle, Matt J. Keeling, Noel D. McCarthy, and Stavros Petrou. 2017. “Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis.” <em>The Lancet Global Health</em> 5 (1). The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license: e51–e59. doi:<a href="https://doi.org/10.1016/S2214-109X(16)30306-0">10.1016/S2214-109X(16)30306-0</a>.</p>
</div>
<div>
<p>Sigurdsson, Samuel, Elias Eythorsson, Birgir Hrafnkelsson, Helga Erlendsdóttir, Karl G Kristinsson, and Ásgeir Haraldsson. 2018. “Reduction in All-Cause Acute Otitis Media in Children &lt;3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.” <em>Clinical Infectious Diseases</em> 67 (8): 1213–9. doi:<a href="https://doi.org/10.1093/cid/ciy233">10.1093/cid/ciy233</a>.</p>
</div>
<div>
<p>Singleton, Rosalyn J., Robert C. Holman, Randall Plant, Krista L. Yorita, Steve Holve, Edna L. Paisano, and James E. Cheek. 2009. “Trends in otitis media and myringtomy with tube placement among American Indian/Alaska native children and the US general population of children.” <em>The Pediatric Infectious Disease Journal</em> 28 (2): 102–7. doi:<a href="https://doi.org/http://dx.doi.org/10.1097/INF.0b013e318188d079">http://dx.doi.org/10.1097/INF.0b013e318188d079</a>.</p>
</div>
<div>
<p>Sloyer, John L, John H Ploussard, and Virgil M Howie. 1981. “Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.” <em>Reviews of Infectious Diseases</em> 3 Suppl: S119–23. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7280444" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/7280444</a>.</p>
</div>
<div>
<p>Smit, Pieter. 1977. “Protective Efficacy of Pneumococcal Polysaccharide Vaccines.” <em>JAMA: The Journal of the American Medical Association</em> 238 (24): 2613. doi:<a href="https://doi.org/10.1001/jama.1977.03280250039019">10.1001/jama.1977.03280250039019</a>.</p>
</div>
<div>
<p>Smolderen, Kim G. 2010. “Health Care Insurance, Financial Concerns in Accessing Care, and Delays to Hospital Presentation in Acute Myocardial Infarction.” <em>JAMA</em> 303 (14). American Medical Association: 1392. doi:<a href="https://doi.org/10.1001/jama.2010.409">10.1001/jama.2010.409</a>.</p>
</div>
<div>
<p>Snaebjarnardóttir, Kolfinna, Helga Erlendsdóttir, Ingi Karl Reynisson, Karl Kristinsson, Sandra Halldórsdóttir, Hjördís Hardardóttir, Thórólfur Gudnason, Magnús Gottfredsson, and Ásgeir Haraldsson. 2013. “Bacterial meningitis in children in Iceland, 1975-2010: a nationwide epidemiological study.” <em>Scandinavian Journal of Infectious Diseases</em> 45 (11): 819–24. doi:<a href="https://doi.org/10.3109/00365548.2013.817680">10.3109/00365548.2013.817680</a>.</p>
</div>
<div>
<p>Song, Joon Young, Moon H. Nahm, and M. Allen Moseley. 2013. “Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance.” <em>Journal of Korean Medical Science</em> 28 (1): 4. doi:<a href="https://doi.org/10.3346/jkms.2013.28.1.4">10.3346/jkms.2013.28.1.4</a>.</p>
</div>
<div>
<p>Sonsuwan, Nuntigar, Patcharin Watcharinyanon, and Kittisak Sawanyawisuth. 2016. “What are the leading causative pathogens in acute otitis media with tympanic membrane perforation?” <em>International Journal of Pediatric Otorhinolaryngology</em> 90 (November). Elsevier Ltd: 20–22. doi:<a href="https://doi.org/10.1016/j.ijporl.2016.08.021">10.1016/j.ijporl.2016.08.021</a>.</p>
</div>
<div>
<p>Spilsbury, Katrina, Abdul Latif Kadhim, James B Semmens, Francis J Lannigan, Spilsbury K., Kadhim A.L., Semmens J.B., et al. 2006. “Decreasing rates of middle ear surgery in Western Australian children.” <em>Archives of Otolaryngology - Head and Neck Surgery</em> 132 (11): 1216–20. doi:<a href="https://doi.org/10.1001/archotol.132.11.1216">10.1001/archotol.132.11.1216</a>.</p>
</div>
<div>
<p>Sternberg, G M. 1882. “A fatal form of septicemia in the rabbit produced by subcutaneous injection of human saliva.” Washington: National Board of Health; U.S. Government Printing Office. <a href="https://books.google.is/books?id=YojXubzmx3sC{\&amp;}printsec=frontcover{\&amp;}hl=is{\#}v=onepage{\&amp;}q{\&amp;}f=false" class="uri">https://books.google.is/books?id=YojXubzmx3sC{\&amp;}printsec=frontcover{\&amp;}hl=is{\#}v=onepage{\&amp;}q{\&amp;}f=false</a>.</p>
</div>
<div>
<p>Stevenson, Mark, Telmo Nunes, Cord Heuer, Jonathon Marshall, Javier Sanchez, Ron Thornton, Jeno Reiczigel, Jim Robison-Cox, Paola Sebastiani, and Peter Solymos. 2017. <em>EpiR: Tools for the Analysis of Epidemiological Data</em>. <a href="https://CRAN.R-project.org/package=epiR" class="uri">https://CRAN.R-project.org/package=epiR</a>.</p>
</div>
<div>
<p>Strutton, David R, Raymond a Farkouh, Stephanie R Earnshaw, Sharon Hwang, Ulrike Theidel, Stathis Kontodimas, Rogier Klok, and Sotiria Papanicolaou. 2012. “Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.” <em>Journal of Infection</em> 64 (1). Elsevier Ltd: 54–67. doi:<a href="https://doi.org/10.1016/j.jinf.2011.10.015">10.1016/j.jinf.2011.10.015</a>.</p>
</div>
<div>
<p>Syrjänen, Ritva K, Kari Auranen, Tuija M Leino, Terhi M Kilpi, and P Helena Mäkelä. 2005. “Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage.” <em>The Pediatric Infectious Disease Journal</em> 24 (9): 801–6. doi:<a href="https://doi.org/10.1097/01.inf.0000178072.83531.4f">10.1097/01.inf.0000178072.83531.4f</a>.</p>
</div>
<div>
<p>Talbird, Sandra E, Thomas N Taylor, Stefanie Knoll, Carl Richard Frostad, and Sebastián García Martí. 2010. “Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.” <em>Vaccine</em> 28 Suppl 6 (November). Elsevier Ltd: G23–9. doi:<a href="https://doi.org/10.1016/j.vaccine.2010.06.016">10.1016/j.vaccine.2010.06.016</a>.</p>
</div>
<div>
<p>Tawfik, Kareem O., Stacey L. Ishman, Mekibib Altaye, Jareen Meinzen-Derr, and Daniel I. Choo. 2017. “Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination.” <em>Otolaryngology-Head and Neck Surgery</em> 156 (5). SAGE PublicationsSage CA: Los Angeles, CA: 938–45. doi:<a href="https://doi.org/10.1177/0194599817699599">10.1177/0194599817699599</a>.</p>
</div>
<div>
<p>Taylor, Sylvia, Paola Marchisio, Anne Vergison, Julie Harriague, William P. Hausdorff, and Mark Haggard. 2012. “Impact of pneumococcal conjugate vaccination on otitis media: A systematic review.” <em>Clinical Infectious Diseases</em> 54 (12): 1765–73. doi:<a href="https://doi.org/10.1093/cid/cis292">10.1093/cid/cis292</a>.</p>
</div>
<div>
<p>Teele, D W, J O Klein, and B Rosner. 1989. “Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.” <em>The Journal of Infectious Diseases</em> 160 (1): 83–94. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2732519" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/2732519</a>.</p>
</div>
<div>
<p>Therneau, Terry M. 2018. <em>Survival: Survival Analysis</em>. <a href="https://CRAN.R-project.org/package=survival" class="uri">https://CRAN.R-project.org/package=survival</a>.</p>
</div>
<div>
<p>Thornton, Ruth B, Paul J Rigby, Selma P Wiertsema, Pierre Filion, Jennifer Langlands, Harvey L Coates, Shyan Vijayasekaran, Anthony D Keil, and Peter C Richmond. 2011. “Multi-species bacterial biofilm and intracellular infection in otitis media.” <em>BMC Pediatrics</em> 11 (1): 94. doi:<a href="https://doi.org/10.1186/1471-2431-11-94">10.1186/1471-2431-11-94</a>.</p>
</div>
<div>
<p>Tillett, W S, M J Cambier, and J E McCormack. 1944. “The Treatment of Lobar Pneumonia and Pneumococcal Empyema with Penicillin.” <em>Bulletin of the New York Academy of Medicine</em> 20 (3): 142–78. doi:<a href="https://doi.org/10.7326/0003-4819-60-5-759">10.7326/0003-4819-60-5-759</a>.</p>
</div>
<div>
<p>Todberg, Tanja, Anders Koch, Mikael Andersson, Sjurdur F. SF F Olsen, Jørgen Lous, Preben Homøe, W Nystad, et al. 2014. “Incidence of otitis media in a contemporary danish national birth cohort.” Edited by C M Schooling. <em>PloS One</em> 9 (12). Public Library of Science: e111732. doi:<a href="https://doi.org/10.1371/journal.pone.0111732">10.1371/journal.pone.0111732</a>.</p>
</div>
<div>
<p>Torné, Adoración Navarro, Joana Gomes Dias, Chantal Quinten, Frantiska Hruba, Marta Cecilia Busana, Pier Luigi Lopalco, Andrew J Amato Gauci, and Lucia Pastore-Celentano. 2014. “European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era.” <em>Vaccine</em> 32 (29): 3644–50. doi:<a href="https://doi.org/10.1016/j.vaccine.2014.04.066">10.1016/j.vaccine.2014.04.066</a>.</p>
</div>
<div>
<p>Tregnaghi, Miguel W. Marcelo, Xavier Sáez-Llorens, Pio López, Hector Abate, Enrique Smith, Adriana Pósleman, Arlene Calvo, et al. 2014. “Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.” Edited by Elizabeth Miller. <em>PLoS Medicine</em> 11 (6). Public Library of Science: e1001657. doi:<a href="https://doi.org/10.1371/journal.pmed.1001657">10.1371/journal.pmed.1001657</a>.</p>
</div>
<div>
<p>Troeger, Christopher, Brigette F Blacker, Ibrahim A Khalil, Puja C Rao, Shujin Cao, Stephanie RM Zimsen, Samuel B Albertson, et al. 2018. “Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.” <em>The Lancet Infectious Diseases</em> 3099 (18): 1–20. doi:<a href="https://doi.org/10.1016/S1473-3099(18)30362-1">10.1016/S1473-3099(18)30362-1</a>.</p>
</div>
<div>
<p>Troeger, Christopher, Mohammad Forouzanfar, Puja C Rao, Ibrahim Khalil, Alexandria Brown, Scott Swartz, Nancy Fullman, et al. 2017. “Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.” <em>The Lancet Infectious Diseases</em> 17 (11). Elsevier: 1133–61. doi:<a href="https://doi.org/10.1016/S1473-3099(17)30396-1">10.1016/S1473-3099(17)30396-1</a>.</p>
</div>
<div>
<p>Tsaban, Gal, and Shalom Ben-Shimol. 2017. “Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.” <em>Vaccine</em> 35 (22): 2882–91. doi:<a href="https://doi.org/10.1016/j.vaccine.2017.04.032">10.1016/j.vaccine.2017.04.032</a>.</p>
</div>
<div>
<p>Tsigrelis, Constantine, Imad M. Tleyjeh, Brian D. Lahr, Lisa M. Nyre, Abinash Virk, and Larry M. Baddour. 2008. “Decreases in Case‐Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995–2007: A Population‐Based Study.” <em>Clinical Infectious Diseases</em> 47 (11): 1367–71. doi:<a href="https://doi.org/10.1086/592970">10.1086/592970</a>.</p>
</div>
<div>
<p>Tuomanen, Elaine I., Robert Austrian, and H. Robert Masure. 1995. “Pathogenesis of Pneumococcal Infection.” Edited by Franklin H. Epstein. <em>New England Journal of Medicine</em> 332 (19): 1280–4. doi:<a href="https://doi.org/10.1056/NEJM199505113321907">10.1056/NEJM199505113321907</a>.</p>
</div>
<div>
<p>Usonis, Vytautas, Teresa Jackowska, Sigita Petraitiene, Alicja Sapala, Andrea Neculau, Izabella Stryjewska, Raghavendra Devadiga, Monica Tafalla, and Katsiaryna Holl. 2016. “Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries.” <em>BMC Pediatrics</em> 16 (1). BioMed Central: 108. doi:<a href="https://doi.org/10.1186/s12887-016-0638-2">10.1186/s12887-016-0638-2</a>.</p>
</div>
<div>
<p>Van Dyke, Melissa K., Jean-Yves Pirçon, Robert Cohen, Shabir A. Madhi, Andrés Rosenblüt, Mercedes Macias Parra, Khalid Al-Mazrou, et al. 2017. “Etiology of Acute Otitis Media in Children Less Than 5 Years of Age.” <em>The Pediatric Infectious Disease Journal</em> 36 (3): 274–81. doi:<a href="https://doi.org/10.1097/INF.0000000000001420">10.1097/INF.0000000000001420</a>.</p>
</div>
<div>
<p>VanderWeele, Tyler J., and Peng Ding. 2017. “Sensitivity Analysis in Observational Research: Introducing the E-Value.” <em>Annals of Internal Medicine</em> 167 (4): 268–74. doi:<a href="https://doi.org/10.7326/M16-2607">10.7326/M16-2607</a>.</p>
</div>
<div>
<p>Venekamp, Roderick P, Paul Mick, Anne GM Schilder, and Desmond A Nunez. 2018. “Grommets (ventilation tubes) for recurrent acute otitis media in children.” <em>Cochrane Database of Systematic Reviews</em> (4):CD0047 (4): CD004741. doi:<a href="https://doi.org/10.1002/14651858.CD012017.pub2">10.1002/14651858.CD012017.pub2</a>.</p>
</div>
<div>
<p>Vergison, Anne, Ron Dagan, Adriano Arguedas, Jan Bonhoeffer, Robert Cohen, Ingeborg DHooge, Alejandro Hoberman, et al. 2010. “Otitis media and its consequences: beyond the earache.” <em>The Lancet Infectious Diseases</em> 10 (3): 195–203. doi:<a href="https://doi.org/10.1016/S1473-3099(10)70012-8">10.1016/S1473-3099(10)70012-8</a>.</p>
</div>
<div>
<p>Vesikari, Timo, Aino Forsten, Ilkka Seppa, Tarja Kaijalainen, Taneli Puumalainen, Anu Soininen, Magali Traskine, et al. 2016. “Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland.” <em>Journal of the Pediatric Infectious Diseases Society</em> 5 (3). doi:<a href="https://doi.org/10.1093/jpids/piw010">10.1093/jpids/piw010</a>.</p>
</div>
<div>
<p>Vlastarakos, Petros V., Thomas P. Nikolopoulos, Stavros Korres, Evangelia Tavoulari, Antonios Tzagaroulakis, and Eleftherios Ferekidis. 2007. “Grommets in otitis media with effusion: the most frequent operation in children. But is it associated with significant complications?” <em>European Journal of Pediatrics</em> 166 (5): 385–91. doi:<a href="https://doi.org/10.1007/s00431-006-0367-x">10.1007/s00431-006-0367-x</a>.</p>
</div>
<div>
<p>Vojtek, Ivo, Marcus Nordgren, and Bernard Hoet. 2017. “Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challenges.” <em>International Journal of Pediatric Otorhinolaryngology</em> 100 (September). Elsevier Ltd: 174–82. doi:<a href="https://doi.org/10.1016/j.ijporl.2017.07.009">10.1016/j.ijporl.2017.07.009</a>.</p>
</div>
<div>
<p>Vooren, K van de, S Duranti, A Curto, and L Garattini. 2014. “Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.” <em>Pharmacoeconomics</em> 32: 29–45. doi:<a href="https://doi.org/10.1007/s40273-013-0113-y">10.1007/s40273-013-0113-y</a>.</p>
</div>
<div>
<p>Wagner, A K, S B Soumerai, F Zhang, and D Ross-Degnan. 2002. “Segmented regression analysis of interrupted time series studies in medication use research.” <em>Journal of Clinical Pharmacy and Therapeutics</em> 27 (4): 299–309. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12174032" class="uri">http://www.ncbi.nlm.nih.gov/pubmed/12174032</a>.</p>
</div>
<div>
<p>Waight, Pauline A., Nicholas J. Andrews, Shamez N. Ladhani, Carmen L. Sheppard, Mary P.E. E Slack, and Elizabeth Miller. 2015. “Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study.” <em>The Lancet Infectious Diseases</em> 15 (5): 535–43. doi:<a href="https://doi.org/10.1016/S1473-3099(15)70044-7">10.1016/S1473-3099(15)70044-7</a>.</p>
</div>
<div>
<p>Walker, Damian G, Raymond Hutubessy, and Philippe Beutels. 2010. “WHO Guide for standardisation of economic evaluations of immunization programmes.” <em>Vaccine</em> 28 (11). Elsevier Ltd: 2356–9. doi:<a href="https://doi.org/10.1016/j.vaccine.2009.06.035">10.1016/j.vaccine.2009.06.035</a>.</p>
</div>
<div>
<p>Wasserman, Matt, Heather L. Sings, Dylan Jones, Sarah Pugh, Margaret Moffatt, and Raymond Farkouh. 2018. “Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.” <em>Expert Review of Vaccines</em> 17 (1). Taylor &amp; Francis: 71–78. doi:<a href="https://doi.org/10.1080/14760584.2018.1409116">10.1080/14760584.2018.1409116</a>.</p>
</div>
<div>
<p>Watson, David A, Daniel M Musher, James W Jacobson, and Jan Verhoef. 1993. “A Brief History of the Pneumococcus in Biomedical Research: A Panoply of Scientific Discovery Description of the Organism and Demonstration of Its Virulence.” <em>Clinical Infectious Diseases</em> 17: 913–24. doi:<a href="https://doi.org/10.1093/clinids/17.5.913">10.1093/clinids/17.5.913</a>.</p>
</div>
<div>
<p>Weichselbaum, A. 1886. “Ueber die Aetiologie der acuten Lungen-und Rippenfellentzundungen.” <em>Medizinische Jahrbücher.</em>, 483–554.</p>
</div>
<div>
<p>Weinberger, Daniel M, Zitta B Harboe, Cécile Viboud, Tyra G Krause, Mark Miller, Kåre Mølbak, and Helle B Konradsen. 2013. “Pneumococcal disease seasonality: incidence, severity, and the role of influenza activity.” <em>The European Respiratory Journal</em>, September, 1–19. doi:<a href="https://doi.org/10.1183/09031936.00056813">10.1183/09031936.00056813</a>.</p>
</div>
<div>
<p>Weinberger, Daniel M, Richard Malley, and Marc Lipsitch. 2011. “Serotype replacement in disease after pneumococcal vaccination.” <em>Lancet</em> 378 (9807): 1962–73. doi:<a href="https://doi.org/10.1016/S0140-6736(10)62225-8">10.1016/S0140-6736(10)62225-8</a>.</p>
</div>
<div>
<p>Weinberger, Daniel M., Zitta B. Harboe, Elisabeth A. M. Sanders, Moses Ndiritu, Keith P. Klugman, Simon Rückinger, Ron Dagan, et al. 2010. “Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis.” <em>Clinical Infectious Diseases</em> 51 (6): 692–99. doi:<a href="https://doi.org/10.1086/655828">10.1086/655828</a>.</p>
</div>
<div>
<p>Weisfelt, Martijn, Diederik van de Beek, Lodewijk Spanjaard, Johannes B Reitsma, and Jan de Gans. 2006. “Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.” <em>The Lancet. Neurology</em> 5 (2): 123–9. doi:<a href="https://doi.org/10.1016/S1474-4422(05)70288-X">10.1016/S1474-4422(05)70288-X</a>.</p>
</div>
<div>
<p>Whitney, C G, T Pilishvili, Monica M Farley, W Schaffner, Allen S Craig, R Lynfield, A C Nyquist, et al. 2006. “Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.” <em>Lancet</em> 368: 1495–1502. doi:<a href="https://doi.org/S0140-6736(06)69637-2 [pii]\r10.1016/S0140-6736(06)69637-2">S0140-6736(06)69637-2 [pii]\r10.1016/S0140-6736(06)69637-2</a>.</p>
</div>
<div>
<p>Wilkinson, Thomas, Mark J. Sculpher, Karl Claxton, Paul Revill, Andrew Briggs, John A. Cairns, Yot Teerawattananon, et al. 2016. “The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.” <em>Value in Health</em> 19 (8). Elsevier: 921–28. doi:<a href="https://doi.org/10.1016/j.jval.2016.04.015">10.1016/j.jval.2016.04.015</a>.</p>
</div>
<div>
<p>Winslow, C.-E. E, Jean Broadhurst, R. E. Buchanan, C Krumwiede, L. A. Rogers, and G. H Smith. 1920. “The Families and Genera of the Bacteria: Final Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types.” <em>Journal of Bacteriology</em> 5 (3): 191–229. doi:<a href="https://doi.org/10.1086/278854">10.1086/278854</a>.</p>
</div>
<div>
<p>World Health Organization Pneumonia Vaccine Trial Investigators’ Group. 2001. “Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children.” Geneva: World Health Organization. <a href="http://www.who.int/iris/handle/10665/66956" class="uri">http://www.who.int/iris/handle/10665/66956</a>.</p>
</div>
<div>
<p>Wright, AlmrothE., W. Parry Morgan, L Colebrook, and R.W. Dodgson. 1914. “Observations ON PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS INFECTIONS. AND ON THE RESULTS WHICH HAVE BEEN ACHIEVED BY IT.” <em>The Lancet</em> 183 (4715): 87–95. doi:<a href="https://doi.org/10.1016/S0140-6736(01)56449-1">10.1016/S0140-6736(01)56449-1</a>.</p>
</div>
<div>
<p>Wu, David Bin-Chia, Nathorn Chaiyakunapruk, Huey-Yi Chong, and Philippe Beutels. 2015. “Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014).” <em>Vaccine</em> 33 (14). Elsevier Ltd: 1633–58. doi:<a href="https://doi.org/10.1016/j.vaccine.2015.01.081">10.1016/j.vaccine.2015.01.081</a>.</p>
</div>
<div>
<p>Yagupsky, P, N Porat, D Fraser, F Prajgrod, M Merires, L McGee, K P Klugman, and R Dagan. 1998. “Acquisition, Carriage, and Transmission of Pneumococci with Decreased Antibiotic Susceptibility in Young Children Attending a Day Care Facility in Southern Israel.” <em>Journal of Infectious Diseases</em> 177 (4): 1003–12. doi:<a href="https://doi.org/10.1086/515239">10.1086/515239</a>.</p>
</div>
<div>
<p>Youngster, Ilan, Jerry Avorn, Valeria Belleudi, Anna Cantarutti, Javier Díez-Domingo, Ursula Kirchmayer, Byung-Joo Park, et al. 2017. “Antibiotic Use in Children – A Cross-National Analysis of 6 Countries.” <em>The Journal of Pediatrics</em> 182 (March). Elsevier Inc.: 239–244.e1. doi:<a href="https://doi.org/10.1016/j.jpeds.2016.11.027">10.1016/j.jpeds.2016.11.027</a>.</p>
</div>
<div>
<p>Zhou, F., Abigail Shefer, J. Wenger, M. Messonnier, L. Y. Wang, A. Lopez, M. Moore, T. V. Murphy, M. Cortese, and L. Rodewald. 2014. “Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009.” <em>PEDIATRICS</em> 133 (4): 577–85. doi:<a href="https://doi.org/10.1542/peds.2013-0698">10.1542/peds.2013-0698</a>.</p>
</div>
<div>
<p>Zhou, Fangjun, Abigail Shefer, Yuan Kong, and J Pekka Nuorti. 2008. “Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.” <em>Pediatrics</em> 121 (2): 253–60. doi:<a href="https://doi.org/10.1542/peds.2007-0619">10.1542/peds.2007-0619</a>.</p>
</div>
<div>
<p>Þórðardóttir, Ásgerður, Helga Erlendsdóttir, Bryndís Sigurðardóttir, Hjördís Harðardóttir, Ingi Karl Reynisson, Magnús Gottfreðsson, and Sigurður Guðmundsson. 2014. “Bacterial meningitis in adults in Iceland, 1995–2010.” <em>Scandinavian Journal of Infectious Diseases</em> 46 (5): 354–60. doi:<a href="https://doi.org/10.3109/00365548.2014.880184">10.3109/00365548.2014.880184</a>.</p>
</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="conclusions.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"download": ["phd_thesis.pdf", "phd_thesis.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "";
    if (src === "" || src === "true") src = "https://cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:" && /^https?:/.test(src))
      src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
